ผลงานหน่วยวิชาระบบทางเดินอาหาร
1. ประชุมวิชาการ
– ประชุมวิชาการสมาคมแพทย์ระบบทางเดินอาหารแห่งประเทศไทย ปีละ 2 ครั้ง
– การประชุมวิชาการระหว่างสถาบัน (Interhospital conference)
2. งานวิจัย
Chitapanarux, Taned| AssociateProfessor
1. Chitapanarux I. , Traisathit P. , Chitapanarux T. , Jiratrachu R. , Chottaweesak P. ,Chakrabandhu S. , Rasio W. , Pisprasert V. , Sripan P. Arginine, glutamine, and shoil supplementation in cancer patients treated with concurrentchemoradiotherapy: A randomized control study (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85066159178&origin=inward) Current Problems inCancer . 2019 JIF : 1.609 JDA
2. Pittayanon R. , Vilaichone R. , Rojborwonwitaya J. , Treeprasertsuk S. , Mairiang P. ,Chirnaksorn S. , Chitapanarux T. , Kaosombatwattana U. , Sottisuporn J. , Sansak I. ,Phisalprapa P . , Bunchorntavakul C. , Chuenrattanakul S. , Chakkaphak S. ,Boonsirichan R. , Wiwattanachang O. , Maneerattanaporn M. , Piyanirun W. ,Leelakusolvong S. , Mahachai V . Thailand dyspepsia guidelines: 2018 (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85060097056&origin=inward) Journal ofNeurogastroenterology and Motility. 25:15-26. 2019 JIF : 3.438
3. Pinyopornpanish K. , Wongsa C. , Thinrungroj N. , Leerapun A. , Pisespongsa P. ,Chitapanarux T. , Thongsawat S. , Kijdamrongthum P. E¨cacy and safety ofendoscopic-guided balloon dilatation without §uoroscopy for the treatment ofachalasia (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85049131072&origin=inward) Journal of the MedicalAssociation of Thailand. 101:S8-S12. 2018
4. Mahatumarat T. , Pinyopornpanish K. , Thinrungroj N. , Leerapun A. , Chitapanarux T. ,Thongsawat S. , Kijdamrongthum P. Etiology, severity and treatment outcomes ofacute pancreatitis in maharaj nakorn Chiang Mai hospital: A retrospective study (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85049130147&origin=inward) Journal of the MedicalAssociation of Thailand. 101:S53-S58. 2018
5. Mahachai V. , Vilaichone R. , Pittayanon R. , Rojborwonwitaya J. , Leelakusolvong S. ,Kositchaiwat C. , Mairiang P. , Praisontarangkul O. , Ovartlarnporn B. , Sottisuporn J. ,Pisespongsa P . , Maneerattanaporn M. , Sony R. , Sirinthornpunya S. ,Chaiyamahapurk O. , Wiwattanachang O. , Sansak I. , Harnsomboon P. , ChitapanaruxT. , Chuenrattanakul S. Thailand consensus on Helicobacter pylori treatment 2015 (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84974625929&origin=inward) Asian Paci¦c Journalof Cancer Prevention. 17:2351-2360. 2016 JIF : 2.514citedby-count: 8
6. Chitapanarux T. , Thongsawat S. , Pisespongsa P. , Leerapun A. , Kijdamrongthum P .Effect of Bi¦dobacterium longum on PPI-based triple therapy for eradication ofHelicobacter pylori: A randomized, double-blind placebo-controlled study (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84922530148&origin=inward) Journal of FunctionalFoods. 13:289-294. 2015 JIF : 4.480citedby-count: 6
7. Chitapanarux T. , Ritdamrongthum P. , Leerapun A. , Pisespongsa P. , Thongsawat S.Three-day versus ¦ve-day somatostatin infusion combination with endoscopicvariceal ligation in the prevention of early rebleeding following acute varicealhemorrhage: A randomized controlled trial (https:/ /www scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84955170414&origin=inward) Hepatology Research. 45:1276-1282. 2015 JIF : 2.218citedby-count: 2
8. Tharavichtikul E. , Meungwong P. , Chitapanarux T. , Chakrabandhu S. , Klunklin P. ,Onchan W. , Wanwilairat S. , Traisathit P. , Galalae R. , Chitapanarux I. Theassociation of rectal equivalent dose in 2 Gy fractions (EQD2) to late rectaltoxicity in locally advanced cervical cancer patients who were valuated byrectosigmoidoscopy in Faculty of Medicine, Chiang Mai University (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84904488761&origin=inward) Radiation OncologyJournal. 32:57-62. 2014 citedby-count: 7 AOI JDA
9. Leerapun A. , Thaikruea L. , Pisespongsa P. , Chitapanarux T. , Praisontarangkul O. ,Thongsawat S. Clinical features and prognostic factors for liver cancer from areferral center in northern Thailand (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84877958458&origin=inward) Journal of the MedicalAssociation of Thailand. 96:531-537. 2013 citedby-count: 4 JDA
10. Chen Y. , Chitapanarux T. , Wu J. , Soon R. , Melton A. , Yee H. Inducible NOSmediates CNP-induced relaxation of intestinal myo¦broblasts (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84878145650&origin=inward) American Journal ofPhysiology – Gastrointestinal and Liver Physiology . 304. 2013 AOI
11. Wu J. , Chitapanarux T . , Chen Y . , Soon R. , Y ee H. Intestinal myo¦broblastsproduce nitric oxide in response to combinatorial cytokine stimulation (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84870402750&origin=inward) Journal of CellularPhysiology. 228:572-580. 2013 JIF : 3.874citedby-count: 7 AOI
12. Chitapanarux I. , Chitapanarux T. , Tharavichitkul E. , Mayurasakorn S. ,Siriwittayakorn P. , Y amada S. , Lorvidhaya V. A phase II study of oxaliplatin with 5-FU/folinic acid and concomitant radiotherapy as a preoperative treatment inpatients with locally advanced rectal cancer (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=83455220049&origin=inward) Biomedical Imagingand Intervention Journal. 7. 2011 citedby-count: 4 JDA
13. Chitapanarux I. , Chitapanarux T. , T raisathit P. , Kudumpee S. , Tharavichitkul E. ,Lorvidhaya V . Randomized controlled trial of live lactobacillus acidophilus plusbi¦dobacterium bi¦dum in prophylaxis of diarrhea during radiotherapy in cervicalcancer patients (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77951800189&origin=inward) Radiation Oncology. 5. 2010 JIF : 2.043citedby-count: 94 JDA
14. Chitapanarux T . , Tienboon P . , Pojchamarnwiputh S. , Leelarungrayub D . Open-labeled pilot study of cysteine-rich whey protein isolate supplementation fornonalcoholic steatohepatitis patients (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=66549084530&origin=inward) Journal ofGastroenterology and Hepatology (Australia). 24:1045-1050. 2009 citedby-count: 27 JDA
15. Chitapanarux T. , Praisontarangkul O. , Ler tprasertsuke N. An open-labeled study ofrebamipide treatment in chronic gastritis patients with dyspeptic symptomsrefractory to proton pump inhibitors
(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=53849105425 &origin=inward) Digestive Diseasesand Sciences. 53:2896-2903. 2008 JIF : 1.448citedby-count: 13 JDA
16. Na-ChiangMai W. , Pojchamarnwiputh S. , Lertprasertsuke N. , Chitapanarux T. CT¦ndings of tuberculous peritonitis (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=47249158129&origin=inward) Singapore MedicalJournal. 49:488-491. 2008 citedby-count: 21 JDAShowing 1 to 21 of 21 entries
17. Namwongprom S. , Ekmahachai M. , Vilasdechanon N. , Chankaew N. , BoonyaprapaS. , Chitapanarux T . Clinical usefulness of per-rectal portal scintigraphy by T c-99mpertechnetate in evaluation of the severity of portal hyper tension in cirrhoticpatients (https:/ /www .scopus.com/inward/record.uri?
partnerID=HzOxMe3b&scp=38449097781&origin=inward) Singapore MedicalJournal. 48:1125-1130. 2007 JDA
18. Chitapanarux T. , Praisontarangkul O. , Thongsawat S. , Pisespongsa P . , Leerapun A.Per rectal portal scintigraphy as a useful tool for predicting esophageal varicealbleeding in cirrhotic patients (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33846988641&origin=inward) World Journal ofGastroenterology. 13:791-795. 2007 citedby-count: 4
19. Chitapanarux T. , Chen S. , Lee H. , Melton A. , Yee H. C-type natriuretic peptide
20. induces human colonic myo¦broblast relaxation (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0346727502&origin=inward) American Journal of
Physiology – Gastrointestinal and Liver Physiology. 286. 2004 citedby-count: 7 AOI
21. Yousukh A. , Jutavijittum P. , Pisetpongsa P. , Chitapanarux T. , Thongsawat S. , SenbaM. , T oriyama K. Clinicopathologic Study of Hepatic Penicillium marneffei inNorthern Thailand (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0742304561&origin=inward) Archives of Pathologyand Laboratory Medicine. 128:191-194. 2004 JIF : 1.410citedby-count: 22 AOIJDA
22. T angkijvanich P. , Melton A. , Chitapanarux T . , Han J. , Y ee H. Platelet-derivedgrowth factor-BB and lysophosphatidic acid distinctly regulate hepaticmyo¦broblast migration through focal adhesion kinase (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0036436701&origin=inward) Experimental CellResearch. 281:140-147. 2002 JIF : 3.860citedby-count: 26 AOIPubmed Publications (not in Scopus) Academic Article: 1
23. Chitapanarux T . , Phornphutkul K. Risk Factors for the Development ofHepatocellular Carcinoma in Thailand(https:/ /www .ncbi.nlm.nih.gov/pubmed/26623264) Journal of clinical andtranslational hepatology . 3:182-8. 2015 citedby-count: 10Web of Science Publications (not in Scopus & Pubmed) Academic Article: 21
24. Chitapanarux T. , Ler tprasertsuke N. , Sangpun P. , Kohsuwan K. Primary gastriclymphoma in Nor thern Thailand JOURNAL OF GASTROENTEROLOGY ANDHEP A TOLOGY . 33:379-379. 2018 JIF : 3.452 JDA
25. Chitapanarux T. , T oworakul C. Boesenbergia rotunda in the treatment of functionaldyspepsia JOURNAL OF GASTROENTEROLOGY AND HEP A TOLOGY. 31:18-18.2016 JIF : 3.504
26. Leerapun A. , Pinyomahakul P . , Kijdamrongthum P. , Chitapanarux T . , Thongsawat S.Low serum HBsAg level predicts HBsAg seroclearance and sustained responsein chronic hepatitis B after stopping oral NUCs HEP A TOLOGY. 64:915A-915A.2016 JIF : 11.055
27. Chitapanarux T. , Ler tprasertsuke N. , Traisathit P . , Sangpun P . , Luevitoonvechakij N.Effect of Helicobacter pylori infection and gastric mucosal histologic features inchronic gastritis patients JOURNAL OF GASTROENTEROLOGY ANDHEP A TOLOGY . 30:129-130. 2015 JIF : 3.627 JDA
28. Pisespongsa P . , Thinrungroj N. , Kijdamrongthum P . , Leerapun A. , Chitapanarux T . ,Thongsawat S. , Praisontharangkul OA. Endoscopic Variceal Ligation (EVL) is Safein Cirrhotic Patients with Severe Thrombocytopenia DIGESTION. 91:97-97. 2015JIF : 2.032
29. Padunwanitchkul P. , Pisespongsa P. , Praisontarangkul O. , Thongsawat S. ,Chitapanarux T. , Leerapun A. , Kitdumrongthum P . Natural History and PrognosticFactors of Acute Complicated Diverticular Diseases in Thailand DIGESTION.91:88-89. 2015 JIF : 2.032
30. Chitapanarux T. , Thongsawat S. , Pisespongsa P . , Leerapun A. , Kijdamrongthum P .Effect of bi¦dobacterium longum on PPI-based triple therapy for eradication ofHelicobacter pylori: a prospective, randomized study JOURNAL OFGASTROENTEROLOGY AND HEP A TOLOGY. 29:23-23. 2014 JIF : 3.325citedby-count: 1
31. Charoentum C. , Chotirosniramit A. , Chitapanarux T . , Sirivanichai C. ,Lertprasertsuke N. , Chewaskulyong B. , Thongprasert S. Attenuated dose ofgemcitabine with cisplatin in patients (pts) with unresectable or metastaticbiliary tract cancer (ABC): Results of single Thai institution JOURNAL OFCLINICAL ONCOLOGY . 31. 2013 JIF : 18.372citedby-count: 1 JDA
32. Thinrungroj N. , Pisespongsa P. , Kijdamrongthum P. , Leerapun A. , Chitapanarux T. ,Thongsawat S. , Praisontarangkul OA. Alginate Accelerates Healing of Post-Endoscopic Variceal Ligation Ulcers: a Randomized-Controlled TrialGASTROINTESTINAL ENDOSCOPY. 75:457-458. 2012 JIF : 5.647citedby-count: 1
33. Pisespongsa P. , Thepsen K. , Kijdamrongdham P. , Leerapun A. , Chitapanarux T . ,Thongsawat S. , Praisontarangkul OA. Causes of mortality in thai patients withacute upper gastrointestinal bleeding (AUGIB) and novel clinical score forpredicting mortality JOURNAL OF GASTROENTEROLOGY AND HEP ATOLOGY.27:433-433. 2012 JIF : 2.410
34. Leerapun A. , Thaikrua L. , Pisespongsa P . , Chitapanarux T . , Praisontarangkul OA. ,Thongsawat S. Clinical feature and prognostic factors for liver cancer amongThailand Referral Center JOURNAL OF GASTROENTEROLOGY ANDHEPATOLOGY . 27:267-268. 2012 JIF : 2.410
35. Pisespongsa P. , Intasri W. , Kijdamrongdham P. , Leerapun A. , Chitapanarux T . ,Thongsawat S. , Praisontarangkul OA. Recent increase of antibiotic-resistantpathogens in Spontaneous Bacterial Peritonitis (SBP) in Northern ThailandJOURNAL OF GASTROENTEROLOGY AND HEP A TOLOGY . 27:265-266. 2012 JIF :2.410
36. Leerapun A. , Soontornpun A. , Pisespongsa P . , Chitapanarux T . , Kijdamrongthum P . ,Thongsawat S. Ribavirin-induced anemia: Incidence and impact to treatmentresponse of chronic hepatitis C JOURNAL OF GASTROENTEROLOGY ANDHEPATOLOGY. 27:267-267. 2012 JIF : 2.410
37. Pisespongsa P. , Praisontarangkul OA. , Hongsongkiat S. , Thongsawat S. , LeerapunA. , Chitapanarux T . Changing in epidemiology of peptic ulcer disease (PUD) andHelicobacter pylori infection in Thailand JOURNAL OF GASTROENTEROLOGYAND HEPATOLOGY. 25:A72-A72. 2010 JIF : 2.275
38. Sripirom P. , Chitapanarux T . Nitric Oxide Disturbance and Chronic Liver DiseaseGASTROENTEROLOGY . 138:S457-S457. 2010 JIF : 12.591
39. Tienboon P. , Chitapanarux T . , Pojchamarnwiputh S. , Leelarungrayub D . EFFECT OFUNDENA TURED CYSTEINE-RICH WHEY PROTEIN ISOLA TE SUPPLEMENTA TIONFOR NONALCOHOLIC F A TTY LIVER DISEASE P A TIENTS ANNALS OF NUTRITIONAND METABOLISM. 55:587-587. 2009 JIF : 1.831 JDA
40. Tienboon P. , Chitapanarux T. , Pojchamarnwiputh S. , Leelarungrayub D .SUPPLEMENTA TION WITH UNDENA TURED CYSTEINE RICH WHEY PROTEINISOLA TE REDUCED OXIDA TIVE STRESS IN P A TIENTS WITH NON ALCOHOLICF A TTY LIVER DISEASE (NAFLD) ANNALS OF NUTRITION AND METABOLISM.55:588-588. 2009 JIF : 1.831 JDA
41. Chitapanarux T. , Tienboon P. , Pojchamarnwiputh S. , Leelarungrayub D. Effect oforal supplement of whey protein isolate on nonalcoholic fatty liver diseaseGASTROENTEROLOGY. 134:A414-A414. 2008 JIF : 12.457 JDA
42. Chitapanarux T . , Praisontarangkul OA. , Thongsawat S. , Pisespongsa R. , LeerapunA. Rebamipide treatment for chronic gastritis with long-term NSAID useDIGESTION. 77:66-66. 2008 JIF : 1.826
43. Pisespongsa P. , Sripotong S. , Chitapanarux T. , Leerapun A. , Thongsawat S. ,Praisontarangkul OA. Serum-ascites albumin concentration gradient (SAAG) morethan 1.5 g/dl predicts esophageal variceal hemorrhage HEP A TOLOGY. 46:602A-602A. 2007 JIF : 9.792
44. Chitapanarux T. , Sudjaritruk S. , Thongsawat S. , Pisespongsa P . , PraisontarangkulO. Three-day versus ¦ve-day treatment with somatostatin or its derivative toprevent early variceal rebleeding in cirrhosis. GASTROENTEROLOGY. 128:A733-A733. 2005 JIF : 12.718citedb
Leerapun, Apinya| Assistant Professor
1. Aurpibul L. , Kanjanavanit S. , Leerapun A. , Puthanakit T . Risk of Liver Fibrosis in Hepatitis B Virus and HIV Coinfected Youths Receiving Tenofovir-Containing Antiretroviral Regimen (https:/ /www .scopus.com/inward/record.uri? partnerID=HzOxMe3b&scp=85062098489&origin=inward) Journal of the International Association of Providers of AIDS Care. 18. 2019
2. Thanapirom K. , Suksawatamnuay S. , Sukeepaisarnjaroen W . , T reeprasertsuk S. , T anwandee T . , Charatcharoenwitthaya P. , Thongsawat S. , Leerapun A. , Piratvisuth T . , Boonsirichan R. , Bunchorntavakul C. , Pattanasirigool C. , Pornthisarn B. , Tuntipanichteerakul S. , Sripariwuth E. , Jeamsripong W. , Sanpajit T. , Poovorawan Y . , Komolmit P. Vitamin D-binding protein gene polymorphism predicts pegylated interferon-related HBsAg seroclearance in HBeAg-negative Thai chronic hepatitis B patients: A multicentre study (https:/ /www .scopus.com/inward/record.uri? partnerID=HzOxMe3b&scp=85065450321&origin=inward) Asian Paci¦c Journal of Cancer Prevention. 20:1257-1264. 2019
3. Thanapirom K. , Suksawatamnuay S. , Sukeepaisarnjaroen W . , T reeprasertsuk S. ,T anwandee T . , Charatcharoenwitthaya P. , Thongsawat S. , Leerapun A. , Piratvisuth T . , Boonsirichan R. , Bunchorntavakul C. , Pattanasirigool C. , Pornthisarn B. , Tuntipanichteerakul S. , Sripariwuth E. , Jeamsripong W. , Sanpajit T. , Poovorawan Y . , Komolmit P. Association of the S267F variant on NTCP gene and treatment response to pegylated interferon in patients with chronic hepatitis B: A multicentre study (https:/ /www .scopus.com/inward/record.uri? partnerID=HzOxMe3b&scp=85042943989&origin=inward) Antiviral Therapy .23:67-75. 2018 JIF : 2.594citedby-count: 2
4. Pinyopornpanish K. , Wongsa C. , Thinrungroj N. , Leerapun A. , Pisespongsa P . , Chitapanarux T . , Thongsawat S. , Kijdamrongthum P . E¨cacy and safety of endoscopic-guided balloon dilatation without §uoroscopy for the treatment of achalasia (https:/ /www .scopus.com/inward/record.uri? partnerID=HzOxMe3b&scp=85049131072&origin=inward) Journal of the Medical Association of Thailand. 101:S8-S12. 2018
5. Mahatumarat T. , Pinyopornpanish K. , Thinrungroj N. , Leerapun A. , Chitapanarux T . , Thongsawat S. , Kijdamrongthum P . Etiology, severity and treatment outcomes of acute pancreatitis in maharaj nakorn Chiang Mai hospital: A retrospective study (https:/ /www .scopus.com/inward/record.uri? partnerID=HzOxMe3b&scp=85049130147&origin=inward) Journal of the Medical Association of Thailand. 101:S53-S58. 2018
6. Thanapirom K. , Suksawatamnuay S. , Sukeepaisarnjareon W . , T anwandee T. , Charatcharoenwitthaya P. , Thongsawat S. , Leerapun A. , Piratvisuth T . , Boonsirichan R. , Bunchorntavakul C. , Pattanasirigool C. , Pornthisarn B. , T antipanichtheerakul S. , Sripariwuth E. , Jeamsripong W . , Sanpajit T. , Poovorawan Y . , Komolmit P. Genetic variation in the Vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter study (https:/ /www .scopus.com/inward/ record.uri? partnerID=HzOxMe3b&scp=85015284826&origin=inward) PLoS ONE. 12. 2017 JIF : 3.057citedby-count: 8
7. Chaiteerakij R. , Barr Fritcher E. , Angsuwatcharakon P. , Ridtitid W. , Chaithongrat S. ,Leerapun A. , Baron T . , Kipp B. , Henry M. , Halling K. , Rerknimitr R. , Roberts L.Fluorescence in situ hybridization compared with conventional cytology for thediagnosis of malignant biliary tract strictures in Asian patients(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84955260001&origin=inward) GastrointestinalEndoscopy . 83:1228-1235. 2016 JIF : 5.369citedby-count: 12 AOIShowing 1 to 13 of 13 entries
8. Chitapanarux T. , Thongsawat S. , Pisespongsa P. , Leerapun A. , Kijdamrongthum P.Effect of Bi¦dobacterium longum on PPI-based triple therapy for eradication ofHelicobacter pylori: A randomized, double-blind placebo-controlled study(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84922530148&origin=inward) Journal of FunctionalFoods. 13:289-294. 2015 JIF : 4.480citedby-count: 6
9. Chitapanarux T. , Ritdamrongthum P. , Leerapun A. , Pisespongsa P . , Thongsawat S.Three-day versus ¦ve-day somatostatin infusion combination with endoscopicvariceal ligation in the prevention of early rebleeding following acute varicealhemorrhage: A randomized controlled trial(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84955170414&origin=inward) Hepatology Research.45:1276-1282. 2015 JIF : 2.218citedby-count: 2
10. Leerapun A. , Thaikruea L. , Pisespongsa P. , Chitapanarux T. , Praisontarangkul O. ,Thongsawat S. Clinical features and prognostic factors for liver cancer from areferral center in northern Thailand (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84877958458&origin=inward) Journal of the MedicalAssociation of Thailand. 96:531-537. 2013 citedby-count: 4 JDA
11. Reddy A. , Dash C. , Leerapun A. , Mettler T . , Stadheim L. , Lazaridis K. , Rober ts R. ,Roberts L. Hypothyroidism: A Possible Risk Factor for Liver Cancer in PatientsWith No Known Underlying Cause of Liver Disease(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33846207926&origin=inward) ClinicalGastroenterology and Hepatology. 5:118-123. 2007 citedby-count: 47 AOI
12. Chitapanarux T. , Praisontarangkul O. , Thongsawat S. , Pisespongsa P. , Leerapun A.Per rectal portal scintigraphy as a useful tool for predicting esophageal varicealbleeding in cirrhotic patients (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33846988641&origin=inward) World Journal ofGastroenterology . 13:791-795. 2007 citedby-count: 4
13. Leerapun A. , Suravarapu S. , Bida J. , Clark R. , Sanders E. , Mettler T. , Stadheim L. ,Aderca I. , Moser C. , Nagorney D. , LaRusso N. , de Groen P. , Menon K. , Lazaridis K. ,Gores G. , Charlton M. , Roberts R. , Therneau T. , Katzmann J. , Rober ts L. {A ¦gureis presented}The Utility of Lens Culinaris Agglutinin-Reactive α-Fetoprotein in theDiagnosis of Hepatocellular Carcinoma: Evaluation in a United States ReferralPopulation (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33947157637&origin=inward) ClinicalGastroenterology and Hepatology . 5:394-402. 2007 citedby-count: 69 AOIWeb of Science Publications (not in Scopus & Pubmed)
14. Phrueksotsai S. , Thongsawat S. , Leerapun A. , Pinyopornpanish K. , Phrueksotsai J., Phrommintikul A. , Chattipakorn N. , Buranapin S. Effect of Dapagli§ozin onHepatic Fat, Visceral Fat and Hepatic In§ammatory Markers in Non-AlcoholicFatty Liver Disease Patients with Type 2 Diabetes HEP A TOLOGY . 68:442A-443A.2018 JIF : 13.246 JDA
15. Sripongpun P. , T angkijvanich P. , Chaiteerakij R. , Poovorawan K. , Sobhonslidsuk A. ,Bunchorntavakul C. , Chirapongsathorn S. , Siramolpiwat S. , Khemnark S. , LeerapunA. , Treeprasertsuk S. , Chotiyaputta W . , Pan-Ngum W. , Soonthornworasiri N. ,Sukeepaisarnjaroen W . EVALUA TION OF BEDSIDE BIOMARKERS ” APRI” AND “FIB4″SCORES FOR HEP A TIC FIBROSIS ASSESSMENT COMP ARED WITH TRANSIENTELASTOGRAPHY (TE) IN CHRONIC HEP A TITIS C P A TIENTSGASTROENTEROLOGY . 154:S1244-S1245. 2018 JIF : 18.392
16. Leerapun A. , Pinyomahakul P. , Kijdamrongthum P. , Chitapanarux T . , Thongsawat S.Low serum HBsAg level predicts HBsAg seroclearance and sustained responsein chronic hepatitis B after stopping oral NUCs HEP A TOLOGY. 64:915A-915A.2016 JIF : 11.055
17. Kitiyakara T. , Leerapun A. , Sutthivanan C. , Poovorawan K. , Pan-Ngum W . ,Soonthornworasiri N. , Chaiteerakij R. , Treeprasertsuk S. , Phaosawasdi K. , MairiangP. , Kositchaiwat C. Regional differences in admissions and treatment outcomesfor patients with hepatocellular carcinoma (HCC) in Thailand: data from thenational universal health care HEPATOLOGY. 64:677A-677A. 2016 JIF : 11.055
18. Thanapirom K. , Suksawatamnuay S. , Sukeepaisarnjaroen W . , T anwandee T . ,Charatcharoenwitthaya P. , Thongsawat S. , Leerapun A. , Piratvisuth T . , BoonsirichanR. , Bunchorntavakul C. , Pattanasirigool C. , Pornthisarn B. , T antipanichtheerakul S. ,Sripariwuth E. , Jeamsripong W. , Sanpajit T. , Poovorawan Y. , Komolmit P. Theassociation of S267F variant on NTCP (SLC10A1), a hepatitis B viral surfacereceptor , and treatment response with pegylated interferon in chronic hepatitis Bpatients: a multicenter study HEP A TOLOGY . 64:291A-291A. 2016 JIF : 11.055
19. Pisespongsa P. , Thinrungroj N. , Kijdamrongthum P. , Leerapun A. , Chitapanarux T. ,Thongsawat S. , Praisontharangkul OA. Endoscopic Variceal Ligation (EVL) is Safein Cirrhotic Patients with Severe Thrombocytopenia DIGESTION. 91:97-97. 2015JIF : 2.032
20. Thanapirom K. , Suksawatamnuay S. , Sukeepaisarnjareon W . , T anwandee T . ,Thongsawat S. , Leerapun A. , Piratvisuth T. , Boonsirichan R. , Bunchorntavakul C. ,Pattanasirigool C. , Pornthisarn B. , T antipanichtheerakul S. , Sripariwuth E. ,Jeamsripong W. , Sanpajit T. , Poovorawan Y. , Komolmit P. INTERFERON-GAMMA-INDUCIBLE PROTEIN 10 PROMOTER POL YMORPHISM RELA TED WITH END-OF-TREA TMENT HBsAg LEVELS AND HAD COMPLEMENTARY ROLE IN PREDICTIONOF SUSTAINED VIROLOGIC RESPONSE TO PEGINTERFERON IN HBeAg-NEGA TIVE CHRONIC HEP A TITIS B: MUL TICENTER STUDY JOURNAL OFHEPATOLOGY . 62:S546-S547. 2015 JIF : 10.401
21. Pisespongsa P. , Bhatia P. , Thongsawat S. , Leerapun A. , Kitdumrongthum P . LowVolume Polyethylene Glycol-Electrolyte Lavage Solution Plus Simple Adjuvant Isas Effective as Sodium Phosphate Solution in the Preparation of Patients forColonoscopy DIGESTION. 91:89-89. 2015 JIF : 2.032
22. Padunwanitchkul P. , Pisespongsa P. , Praisontarangkul O. , Thongsawat S. ,Chitapanarux T . , Leerapun A. , Kitdumrongthum P . Natural History and PrognosticFactors of Acute Complicated Diverticular Diseases in Thailand DIGESTION.91:88-89. 2015 JIF : 2.032
23. Thanapirom K. , Suksawatamnuay S. , Poovorawan K. , Sukeepaisarnjaroen W . ,T anwandee T. , Thongsawat S. , Leerapun A. , Piratvisuth T . , Boonsirichan R. ,Bunchorntavakul C. , Pattanasirigool C. , Pornthisarn B. , T antipanichtheerakul S. ,Sripariwuth E. , Jeamsripong W . , Sanpajit T. , Komolmit P . The Single NucleotidePolymorphism in the Vitamin D Pathway DHCR7 Gene and Pre-Treatment HBV-DNA Strongly Predict HBeAg Loss in HBeAg-Positive Chronic Hepatitis B PatientsTreated With Pegylated Interferon: Multicenter Study GASTROENTEROLOGY .148:S1066-S1066. 2015 JIF : 13.926
24. Chitapanarux T. , Thongsawat S. , Pisespongsa P. , Leerapun A. , Kijdamrongthum P.Effect of dobacterium longum on PPI-based triple therapy for eradication ofHelicobacter pylori: a prospective, randomized study JOURNAL OFGASTROENTEROLOGY AND HEP A TOLOGY . 29:23-23. 2014 JIF : 3.325citedby-count: 1
25. Thinrungroj N. , Pisespongsa P . , Kijdamrongthum P. , Leerapun A. , Chitapanarux T . ,Thongsawat S. , Praisontarangkul OA. Alginate Accelerates Healing of Post-Endoscopic Variceal Ligation Ulcers: a Randomized-Controlled TrialGASTROINTESTINAL ENDOSCOPY. 75:457-458. 2012 JIF : 5.647citedby-count: 1
26. Pisespongsa P . , Thepsen K. , Kijdamrongdham P. , Leerapun A. , Chitapanarux T . ,Thongsawat S. , Praisontarangkul OA. Causes of mortality in thai patients withacute upper gastrointestinal bleeding (AUGIB) and novel clinical score forpredicting mortality JOURNAL OF GASTROENTEROLOGY AND HEP A TOLOGY .27:433-433. 2012 JIF : 2.410
27. Leerapun A. , Thaikrua L. , Pisespongsa P . , Chitapanarux T. , Praisontarangkul OA. ,Thongsawat S. Clinical feature and prognostic factors for liver cancer amongThailand Referral Center JOURNAL OF GASTROENTEROLOGY ANDHEP A TOLOGY . 27:267-268. 2012 JIF : 2.410
28. Pisespongsa P. , Intasri W. , Kijdamrongdham P. , Leerapun A. , Chitapanarux T . ,Thongsawat S. , Praisontarangkul OA. Recent increase of antibiotic-resistantpathogens in Spontaneous Bacterial Peritonitis (SBP) in Northern ThailandJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 27:265-266. 2012 JIF :2.410
29. Leerapun A. , Soontornpun A. , Pisespongsa P . , Chitapanarux T . , Kijdamrongthum P . ,Thongsawat S. Ribavirin-induced anemia: Incidence and impact to treatmentresponse of chronic hepatitis C JOURNAL OF GASTROENTEROLOGY ANDHEPATOLOGY . 27:267-267. 2012 JIF : 2.410
30. Pisespongsa P . , Praisontarangkul OA. , Hongsongkiat S. , Thongsawat S. , LeerapunA. , Chitapanarux T . Changing in epidemiology of peptic ulcer disease (PUD) andHelicobacter pylori infection in Thailand JOURNAL OF GASTROENTEROLOGYAND HEPATOLOGY . 25:A72-A72. 2010 JIF : 2.275
31. Chitapanarux T . , Praisontarangkul OA. , Thongsawat S. , Pisespongsa R. , LeerapunA. Rebamipide treatment for chronic gastritis with long-term NSAID useDIGESTION. 77:66-66. 2008 JIF : 1.826Pisespongsa P . , Sripotong S. , Chitapanarux T . , Leerapun A. , Thongsawat S. ,Praisontarangkul OA. Serum-ascites albumin concentration gradient (SAAG) morethan 1.5 g/dl predicts esophageal variceal hemorrhage HEPATOLOGY . 46:602A-602A. 2007 JIF : 9.792
32. Leerapun A. , Suravarapu V . , Bida JP . , Clark RJ. , Sanders EL. , Mettler T A. ,Stadheim LM. , Aderca I. , Moser CD . , Nagorney DM. , Larusso NF . , de Green PC. ,Menon KVN. , Lazandis KN. , Gores GJ. , Charlton MR. , Roberts RO . , Themeau TM. ,Katzmann JA. , Roberts L. The utility of serum AFP-L3% in the diagnosis ofhepatocellular carcinoma: Evaluation in a US referral populationGASTROENTEROLOGY . 130:A774-A775. 2006 JIF : 13.092
33. Reddy A. , Dash C. , Leerapun A. , Mettler T . , Stadheim L. , Rober ts L.Hypothyroidism: A risk factor for hepatocellular carcinoma (hcc) in patients withno known underlying cause of liver disease GASTROENTEROLOGY . 128:A759-A759. 2005 JIF : 12.718
Kijdamrongthum, Phuripong| Assistant Professor
1. Pinyopornpanish K. , Wongsa C. , Thinrungroj N. , Leerapun A. , Pisespongsa P . , Chitapanarux T . , Thongsawat S. , Kijdamrongthum P . E¨cacy and safety of endoscopic-guided balloon dilatation without §uoroscopy for the treatment of achalasia (https:/ /www .scopus.com/inward/record.uri? partnerID=HzOxMe3b&scp=85049131072&origin=inward) Journal of the Medical Association of Thailand. 101:S8-S12. 2018
2. Mahatumarat T . , Pinyopornpanish K. , Thinrungroj N. , Leerapun A. , Chitapanarux T . , Thongsawat S. , Kijdamrongthum P . Etiology , severity and treatment outcomes of acute pancreatitis in maharaj nakorn Chiang Mai hospital: A retrospective study (https:/ /www .scopus.com/inward/record.uri? partnerID=HzOxMe3b&scp=85049130147&origin=inward) Journal of the Medical Association of Thailand. 101:S53-S58. 2018
3. Tippawangkosol P . , Saingamsook J. , Kijdamrongthum P . , Thinrungroj N. , Jariyawat K. , Somboon P . Endoscopic management of biliary fascioliasis and identi¦cation of fasciola §uke based on mitochondrial DNA: A case report from Thailand (https:/ /www .scopus.com/inward/record.uri? partnerID=HzOxMe3b&scp=85041099353&origin=inward) Southeast Asian Journal of Tropical Medicine and Public Health. 48:524-531. 2017
4. Chitapanarux T . , Thongsawat S. , Pisespongsa P . , Leerapun A. , Kijdamrongthum P . Effect of Bi¦dobacterium longum on PPI-based triple therapy for eradication of Helicobacter pylori: A randomized, double-blind placebo-controlled study (https:/ /www .scopus.com/inward/record.uri? partnerID=HzOxMe3b&scp=84922530148&origin=inward) Journal of Functional Foods. 13:289-294. 2015 JIF : 4.480citedby-count: 6 Web of Science Publications (not in Scopus & Pubmed)
5. Tepmalai K. , Kijdamrongthum P . , Damrongmanee A. Endoscopic retrograde cholangiopancreatography in the management of pancreaticobilliary disorders in pediatric age group JOURNAL OF GASTROENTEROLOGY AND HEP A TOLOGY . 31:328-328. 2016
6. Leerapun A. , Pinyomahakul P . , Kijdamrongthum P. , Chitapanarux T . , Thongsawat S. Low serum HBsAg level predicts HBsAg seroclearance and sustained response in chronic hepatitis B after stopping oral NUCs HEP A TOLOGY . 64:915A-915A. 2016
7. Pisespongsa P . , Thinrungroj N. , Kijdamrongthum P. , Leerapun A. , Chitapanarux T . , Thongsawat S. , Praisontharangkul OA. Endoscopic Variceal Ligation (EVL) is Safe in Cirrhotic Patients with Severe Thrombocytopenia DIGESTION. 91:97-97. 2015
8. Chitapanarux T. , Thongsawat S. , Pisespongsa P. , Leerapun A. , Kijdamrongthum P . Effect of bi¦dobacterium longum on PPI-based triple therapy for eradication of Helicobacter pylori: a prospective, randomized study JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. 29:23-23. 2014 JIF : 3.325citedby-count: 1
9. Thinrungroj N. , Pisespongsa P. , Kijdamrongthum P. , Leerapun A. , Chitapanarux T . , Thongsawat S. , Praisontarangkul OA. Alginate Accelerates Healing of Post-Endoscopic Variceal Ligation Ulcers: a Randomized-Controlled Trial GASTROINTESTINAL ENDOSCOPY . 75:457-458. 2012 JIF : 5.647citedby-count: 1
10. Leerapun A. , Soontornpun A. , Pisespongsa P. , Chitapanarux T. , Kijdamrongthum P. ,Thongsawat S. Ribavirin-induced anemia: Incidence and impact to treatment response of chronic hepatitis C JOURNAL OF GASTROENTEROLOGY ANDHEPATOLOGY. 27:267-267. 2012
Thinrungroj, Nithi| Instructor
1. Pinyopornpanish K. , Wongsa C. , Thinrungroj N. , Leerapun A. , Pisespongsa P . , Chitapanarux T . , Thongsawat S. , Kijdamrongthum P . E¨cacy and safety of endoscopic-guided balloon dilatation without §uoroscopy for the treatment of achalasia (https:/ /www .scopus.com/inward/record.uri? partnerID=HzOxMe3b&scp=85049131072&origin=inward) Journal of the Medical Association of Thailand. 101:S8-S12. 2018
2. Mahatumarat T . , Pinyopornpanish K. , Thinrungroj N. , Leerapun A. , Chitapanarux T . , Thongsawat S. , Kijdamrongthum P . Etiology , severity and treatment outcomes of acute pancreatitis in maharaj nakorn Chiang Mai hospital: A retrospective study (https:/ /www .scopus.com/inward/record.uri? partnerID=HzOxMe3b&scp=85049130147&origin=inward) Journal of the Medical Association of Thailand. 101:S53-S58. 2018
3. Tippawangkosol P . , Saingamsook J. , Kijdamrongthum P . , Thinrungroj N. , Jariyawat K. , Somboon P . Endoscopic management of biliary fascioliasis and identi¦cation of fasciola §uke based on mitochondrial DNA: A case report from Thailand (https:/ /www .scopus.com/inward/record.uri? partnerID=HzOxMe3b&scp=85041099353&origin=inward) Southeast Asian Journal of Tropical Medicine and Public Health. 48:524-531. 2017
4. Pisespongsa P . , Thinrungroj N. , Kijdamrongthum P . , Leerapun A. , Chitapanarux T . , Thongsawat S. , Praisontharangkul OA. Endoscopic Variceal Ligation (EVL) is Safe in Cirrhotic Patients with Severe Thrombocytopenia DIGESTION. 91:97-97. 2015
5. Thinrungroj N. , Pisespongsa P . , Kijdamrongthum P . , Leerapun A. , Chitapanarux T . , Thongsawat S. , Praisontarangkul OA. Alginate Accelerates Healing of Post-Endoscopic Variceal Ligation Ulcers: a Randomized-Controlled TrialGASTROINTESTINAL ENDOSCOPY . 75:457-458. 2012
Pinyopornpanish, Kanokwan| Assistant Professor
1. Pinyopornpanish K. , Wongsa C. , Thinrungroj N. , Leerapun A. , Pisespongsa P . ,Chitapanarux T . , Thongsawat S. , Kijdamrongthum P . E¨cacy and safety ofendoscopic-guided balloon dilatation without §uoroscopy for the treatment ofachalasia (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85049131072&origin=inward) Journal of the MedicalAssociation of Thailand. 101:S8-S12. 2018
2. Mahatumarat T. , Pinyopornpanish K. , Thinrungroj N. , Leerapun A. , Chitapanarux T . ,Thongsawat S. , Kijdamrongthum P . Etiology , severity and treatment outcomes ofacute pancreatitis in maharaj nakorn Chiang Mai hospital: A retrospective study(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85049130147&origin=inward) Journal of the MedicalAssociation of Thailand. 101:S53-S58. 2018
3. Thaikla K. , Pinyopornpanish K. , Jiraporncharoen W . , Angkurawaranon C. Cannabisand Kratom online information in Thailand: Facebook trends 2015-2016(https:/ /www ncbi.nlm.nih.gov/pubmed/29743100) Substance abuse treatment,prevention, and policy . 13:15. 2018
4. Pinyopornpanish K. , Jiraporncharoen W . , Thaikla K. , Yoonut K. , Angkurawaranon C.Sedative and Analgesic Drugs Online: A Content Analysis of the Supply andDemand Information Available in Thailand(https:/ /www .ncbi.nlm.nih.gov/pubmed/28910188) Substance use & misuse.53:641-647. 2018 citedby-count: 1 JDA
5. Thanamee S. , Pinyopornpanish K. , Wattanapisit A. , Suerungruang S. , Thaikla K. ,Jiraporncharoen W . , Angkurawaranon C. A population-based survey on physicalinactivity and leisure time physical activity among adults in Chiang Mai, Thailand,2014 (https:/ /www .ncbi.nlm.nih.gov/pubmed/29026542) Archives of publichealth = Archives belges de sante publique. 75:41. 2017
6. Jiraniramai S. , Jiraporncharoen W . , Pinyopornpanish K. , Jakkaew N. , WongpakaranT . , Angkurawaranon C. Functional beliefs and risk minimizing beliefs among Thaihealthcare workers in Maharaj Nakorn Chiang Mai hospital: its association withintention to quit tobacco and alcohol(https:/ /www .ncbi.nlm.nih.gov/pubmed/28701196) Substance abuse treatment,prevention, and policy. 12:34. 2017 citedby-count: 1 JDA
7. Pinyopornpanish K. , Thanamee S. , Jiraporncharoen W. , Thaikla K. , McDonald J. ,Aramrattana A. , Angkurawaranon C. Sexual health, risky sexual behavior andcondom use among adolescents young adults and older adults in Chiang Mai,Thailand: ¦ndings from a population based survey(https:/ /www .ncbi.nlm.nih.gov/pubmed/29202883) BMC research notes. 10:682.2017
8. Pinyopornpanish K. , Chaiwarith R. , Pantip C. , Keawvichit R. , Wongworapat K. ,Khamnoi P . , Supparatpinyo K. , Sirisanthana T . Comparison of Xpert MTB/RIFAssay and the Conventional Sputum Microscopy in Detecting Mycobacteriumtuberculosis in Northern Thailand(https:/ /www .ncbi.nlm.nih.gov/pubmed/26064681) Tuberculosis research andtreatment. 2015:571782. 2015
9. Dornan L. , Pinyopornpanish K. , Jiraporncharoen W . , Hashmi A. , Dejkriengkraikul N., A ngkurawaranon C. Utilisation of Electronic Health Records for Public Health inAsia: A Review of Success Factors and Potential Challenges BIOMED RESEARCHINTERNATIONAL. 2019. 2019
10. Phrueksotsai S. , Thongsawat S. , Leerapun A. , Pinyopornpanish K. , Phrueksotsai J., Phrommintikul A. , Chattipakorn N. , Buranapin S. Effect of Dapagli§ozin onHepatic Fat, Visceral Fat and Hepatic In§ammatory Markers in Non-AlcoholicFatty Liver Disease Patients with Type 2 Diabetes HEP A TOLOGY . 68:442A-443A.2018
11. Pinyopornpanish K. , Kijdamrongtham P . , Soontornpun A. , Teeyasoontranon W . ,Angkurawaranon C. , Thongsawat S. The effect of prucalopride on gastricemptying in Parkinson ‘ s disease patients, a pilot randomized, open-label studyJOURNAL OF GASTROENTEROLOGY AND HEP A TOLOGY . 31:113-113. 2016
Thongsawat, Satawat| AssociateProfessor
1. Wei L. , Lim S. , Xie Q. , Văn K. , Piratvisuth T . , Huang Y . , Wu S. , Xu M. , T ang H. ,Cheng J. , Le Manh H. , Gao Y . , Mou Z. , Sobhonslidsuk A. , Dou X. , Thongsawat S. ,Nan Y . , T an C. , Ning Q. , Tee H. , Mao Y . , Stamm L. , Lu S. , Dvory-Sobol H. , Mo H. ,Brainard D . , Y ang Y . , Dao L. , Wang G. , T anwandee T . , Hu P. , T angkijvanich P. ,Zhang L. , Gao Z. , Lin F. , Le T. , Shang J. , Gong G. , Li J. , Su M. , Duan Z. , MohamedR. , Hou J. , Jia J. Sofosbuvir–velpatasvir for treatment of chronic hepatitis Cvirus infection in Asia: a single-arm, open-label, phase 3 trial(https:/ /www scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85059554222&origin=inward) The LancetGastroenterology and Hepatology . 4:127-134. 2019 citedby-count: 6 AOI
2. Thanapirom K. , Suksawatamnuay S. , Sukeepaisarnjaroen W . , T reeprasertsuk S. ,T anwandee T . , Charatcharoenwitthaya P . , Thongsawat S. , Leerapun A. , PiratvisuthT . , Boonsirichan R. , unchorntavakul C. , Pattanasirigool C. , Pornthisarn B. ,Tuntipanichteerakul S. , Sripariwuth E. , Jeamsripong W . , Sanpajit T . , Poovorawan Y ., Komolmit P . Vitamin D-binding protein gene polymorphism predicts pegylatedinterferon-related HBsAg seroclearance in HBeAg-negative Thai chronic hepatitisB patients: A multicentre study (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065450321&origin=inward) Asian Paci¦c Journalof Cancer Prevention. 20:1257-1264. 2019
3. Thanapirom K. , Suksawatamnuay S. , Sukeepaisarnjaroen W . , T reeprasertsuk S. ,T anwandee T . , Charatcharoenwitthaya P . , Thongsawat S. , Leerapun A. , PiratvisuthT . , Boonsirichan R. , Bunchorntavakul C. , Pattanasirigool C. , Pornthisarn B. ,Tuntipanichteerakul S. , Sripariwuth E. , Jeamsripong W . , Sanpajit T . , Poovorawan Y ., Komolmit P . Association of the S267F variant on NTCP gene and treatmentresponse to pegylated interferon in patients with chronic hepatitis B: Amulticentre study (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85042943989&origin=inward) Antiviral Therapy .23:67-75. 2018 JIF : 2.594citedby-count: 2
4. Pinyopornpanish K. , Wongsa C. , Thinrungroj N. , Leerapun A. , Pisespongsa P . ,Chitapanarux T . , Thongsawat S. , Kijdamrongthum P . E¨cacy and safety ofendoscopic-guided balloon dilatation without §uoroscopy for the treatment ofachalasia (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85049131072&origin=inward) Journal of the MedicalAssociation of Thailand. 101:S8-S12. 2018
5. Mahatumarat T . , Pinyopornpanish K. , Thinrungroj N. , Leerapun A. , Chitapanarux T . ,Thongsawat S. , Kijdamrongthum P . Etiology , severity and treatment outcomes ofacute pancreatitis in maharaj nakorn Chiang Mai hospital: A retrospective study(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85049130147&origin=inward) Journal of the MedicalAssociation of Thailand. 101:S53-S58. 2018
6. Sornsuvit C. , Hongwiset D. , Y otsawimonwat S. , T oonkum M. , Thongsawat S. ,T aesotikul W . The Bioavailability and Pharmacokinetics of Silymarin SMEDDSFormulation Study in Healthy Thai Volunteers(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85051031069&origin=inward) Evidence-basedComplementary and Alternative Medicine. 2018. 2018 JIF : 1.740citedby-count:
7. Thanapirom K. , Suksawatamnuay S. , Sukeepaisarnjareon W . , T anwandee T . ,Charatcharoenwitthaya P. , Thongsawat S. , Leerapun A. , Piratvisuth T . , BoonsirichanR. , Bunchorntavakul C. , Pattanasirigool C. , Pornthisarn B. , T antipanichtheerakul S. ,Sripariwuth E. , Jeamsripong W. , Sanpajit T. , Poovorawan Y . , Komolmit P . Geneticvariation in the Vitamin D pathway CYP2R1 gene predicts sustained HBeAgseroconversion in chronic hepatitis B patients treated with pegylated interferon:A multicenter study (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85015284826&origin=inward) PLoS ONE. 12. 2017
8. Kumthip K. , Chusri P . , Pantip C. , Thongsawat S. , O’Brien A. , Maneekarn N.Analysis of mutations in the core and NS5A genes of hepatitis C virus in non-responder and relapser patients after treatment with Peg-IFN-αand ribavirin(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84958741512&origin=inward) VirusDisease. 27:55-62. 2016 citedby-count: 1 JDA
9. Jourdain G. , Ngo-Giang-Huong N. , Cressey T. , Hua L. , Harrison L. , Tierney C. ,Salvadori N. , Decker L. , Traisathit P . , Sirirungsi W . , Khamduang W. ,Bowonwatanuwong C. , Puthanakit T . , Siberry G. , Watts D . , Murphy T. , AchalapongJ. , Hongsiriwon S. , Klinbuayaem V . , Thongsawat S. , Chung R. , Pol S. , ChotivanichN. Prevention of mother-to-child transmission of hepatitis B virus: A phase III,placebo-controlled, double-blind, randomized clinical trial to assess the e¨cacyand safety of a short course of tenofovir disoproxil fumarate in women withhepatitis B virus e-antigen (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84981186408&origin=inward) BMC InfectiousDiseases. 16. 2016 JIF : 2.613citedby-count: 13 AOI
10. Kao J. , Tung S. , Lee Y . , Thongsawat S. , T anwandee T . , Sheen I. , Wu J. , Li H. ,Brennan B. , Zhou J. , Le Pogam S. , Najera I. , Thommes J. , Hill G. Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronichepatitis C patients with or without cirrhosis(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85002152541&origin=inward) Journal ofGastroenterology and Hepatology (Australia). 31:1757-1765. 2016 citedby-count:4 AOI
11. Charatcharoenwitthaya P. , Sukeepaisarnjaroen W. , Piratvisuth T. , Thongsawat S. ,Sanpajit T . , Chonprasertsuk S. , Jeamsripong W . , Sripariwuth E. , Komolmit P . ,Patcharatrakul T . , Boonsirichan R. , Bunchorntavakul C. , Tuntipanichteerakul S. ,T anwandee T . Treatment outcomes and validation of the stopping rule forresponse to peginterferon in chronic hepatitis B: A Thai nationwide cohor t study(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84996565533&origin=inward) Journal ofGastroenterology and Hepatology (Australia). 31:1874-1881. 2016 citedby-count:1
12. Chitapanarux T . , Thongsawat S. , Pisespongsa P . , Leerapun A. , Kijdamrongthum P .Effect of Bi¦dobacterium longum on PPI-based triple therapy for eradication ofHelicobacter pylori: A randomized, double-blind placebo-controlled study(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84922530148&origin=inward) Journal of FunctionalFoods. 13:289-294. 2015 JIF : 4.480citedby-count: 6
13. Chusri P. , Kumthip K. , Pantip C. , Thongsawat S. , O’Brien A. , Maneekarn N.In§uence of amino acid variations in the NS3, NS4A and NS4B of HCV genotypes1a, 1b, 3a, 3b and 6f on the response to pegylated interferon and ribavirincombination therapy (https:/ /www scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84920735754&origin=inward) Virus Research.196:37-43. 2015 JIF : 2.827citedby-count: 3 JDA
14. Zeuzem S. , Flisiak R. , Vierling J. , Mazur W . , Mazzella G. , Thongsawat S. ,Abdurakhmanov D . , Van Kính N. , Calistru P. , Heo J. , Stanciu C. , Gould M. , MakaraM. , Hsu S. , Buggisch P . , Samuel D . , Mutimer D . , Nault B. , Merz M. , Bao W . , GriffelL. , Brass C. , Naoumov N. Randomised clinical trial: Alisporivir combined withpeginterferon and ribavirin in treatment-naïve patients with chronic HCVgenotype 1 infection (ESSENTIAL II)(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84940788102&origin=inward) AlimentaryPharmacology and Therapeutics. 42:829-844. 2015 JIF : 5.478citedby-count: 19
15. Colvin R. , T anwandee T. , Piratvisuth T. , Thongsawat S. , Hui A. , Zhang H. , Ren H. ,Chen P . , Chuang W. , Sobhonslidsuk A. , Li R. , Qi Y . , Praestgaard J. , Han Y . , Xu J. ,Stein D . , Chien R. , Flisiak R. , Jablkowski M. , Liaw Y. , Sung J. Randomized,controlled pharmacokinetic and pharmacodynamic evaluation of albinterferon inpatients with chronic hepatitis B infection(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84919608802&origin=inward) Journal ofGastroenterology and Hepatology (Australia). 30:184-191. 2015 citedby-count: 2AOI
16. Chitapanarux T . , Ritdamrongthum P . , Leerapun A. , Pisespongsa P . , Thongsawat S.Three-day versus ¦ve-day somatostatin infusion combination with endoscopicvariceal ligation in the prevention of early rebleeding following acute varicealhemorrhage: A randomized controlled trial(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84955170414&origin=inward) Hepatology Research.45:1276-1282. 2015 JIF : 2.218citedby-count: 2
17. Kumthip K. , Chusri P . , Pantip C. , Thongsawat S. , O’Brien A. , Nelson K. , ManeekarnN. Hepatitis C virus genotypes circulating in patients with chronic hepatitis C inThailand and their responses to combined PEG-IFN and RBV therapy(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84901801479&origin=inward) Journal of MedicalVirology . 86:1360-1365. 2014 JIF : 2.373citedby-count: 4 AOI JDA
18. Vasavid P . , Chaiwatanarat T . , Pusuwan P . , Sritara C. , Roysri K. , Namwongprom S. ,Kuanrakcharoen P . , Premprabha T . , Chunler trith K. , Thongsawat S. , SirinthornpunyaS. , Ovartlarnporn B. , Kachintorn U. , Leelakusolvong S. , Kositchaiwat C. ,Chakkaphak S. , Gonlachanvit S. Normal solid gastric emptying values measuredby scintigraphy using asian-style meal: A multicenter study in healthy volunteers(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84903995888&origin=inward) Journal ofNeurogastroenterology and Motility. 20:371-378. 2014 citedby-count: 22 JDA
19. Thongsawat S. , Piratvisuth T . , Pramoolsinsap C. , Chutaputti A. , T anwandee T . ,Thongsuk D . Resource utilization and direct medical costs of chronic hepatitis Cin Thailand: A heavy but manageable economic burden(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84896734786&origin=inward) Value in HealthRegional Issues. 3:12-18. 2014 citedby-count: 5
20. Leerapun A. , Thaikruea L. , Pisespongsa P . , Chitapanarux T . , Praisontarangkul O . ,Thongsawat S. Clinical features and prognostic factors for liver cancer from areferral center in northern Thailand (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84877958458&origin=inward) Journal of the MedicalAssociation of Thailand. 96:531-537. 2013 citedby-count: 4 JDA
21. Foster G. , Zeuzem S. , Pianko S. , Sarin S. , Piratvisuth T . , Shah S. , Andreone P . ,Sood A. , Chuang W . , Lee C. , George J. , Gould M. , Flisiak R. , Jacobson I. ,Komolmit P . , Thongsawat S. , T anwandee T . , Rasenack J. , Sola R. , Messina I. , YinY . , Cammarata S. , Feutren G. , Brown K. Decline in pulmonary function duringchronic hepatitis C virus therapy with modi¦ed interferon alfa and ribavirin(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84875216158&origin=inward) Journal of ViralHepatitis. 20. 2013 JIF : 4.088citedby-count: 12 AOI
22. Wang Y . , Thongsawat S. , Gane E. , Liaw Y . , Jia J. , Hou J. , Chan H. , PapatheodoridisG. , Wan M. , Niu J. , Bao W . , T rylesinski A. , Naoumov N. E¨cacy and safety ofcontinuous 4-year telbivudine treatment in patients with chronic hepatitis B(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84875229260&origin=inward) Journal of ViralHepatitis. 20. 2013 JIF : 4.088citedby-count: 63 AOI
23. Moreno C. , Berg T . , T anwandee T . , Thongsawat S. , Van Vlierberghe H. , Zeuzem S. ,Lenz O . , Peeters M. , Sekar V . , De Smedt G. Antiviral activity of TMC435monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, aphase IIa, open-label study (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84861188748&origin=inward) Journal of Hepatology .56:1247-1253. 2012 JIF : 9.334citedby-count: 85 AOI
24. Kumthip K. , Chusri P . , Jilg N. , Zhao L. , Fusco D . , Zhao H. , Goto K. , Cheng D . ,Schaefer E. , Zhang L. , Pantip C. , Thongsawat S. , O’Brien A. , Peng L. , ManeekarnN. , Chung R. , Lin W . Hepatitis C virus NS5A disrupts STA T1 phosphorylation andsuppresses type I interferon signaling(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84865086668&origin=inward) Journal of Virology .86:8581-8591. 2012 JIF : 5.189citedby-count: 50 AOI JDA
25. Pianko S. , Zeuzem S. , Chuang W . , Foster G. , Sarin S. , Flisiak R. , Lee C. , AndreoneP . , Piratvisuth T . , Shah S. , Sood A. , George J. , Gould M. , Komolmit P . , ThongsawatS. , T anwandee T . , Rasenack J. , Li Y . , Pang M. , Yin Y . , Feutren G. , Jacobson I.Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis Cvirus genotype 2/3 (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84864665171&origin=inward) Journal of ViralHepatitis. 19:623-634. 2012 JIF : 3.502citedby-count: 9 AOI
26. Kumthip K. , Pantip C. , Chusri P . , Thongsawat S. , O’Brien A. , Nelson K. , ManeekarnN. Correlation between mutations in the core and NS5A genes of hepatitis C virusgenotypes 1a, 1b, 3a, 3b, 6f and the response to pegylated interferon and ribavirincombination therapy (https:/ /www scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79952652957&origin=inward) Journal of ViralHepatitis. 18. 2011 JIF : 3.348citedby-count: 18 AOI JDA
27. Gane E. , Wang Y . , Liaw Y . , Hou J. , Thongsawat S. , Wan M. , Moon Y . , Jia J. , ChaoY . , Niu J. , Leung N. , Samuel D . , Hsu C. , Bao W . , Lopez P . , Avila C. E¨cacy andsafety of prolonged 3-year telbivudine treatment in patients with chronic hepatitisB (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79953315167&origin=inward) Liver International.31:676-684. 2011 JIF : 2.987citedby-count: 42 AOI
28. Patel K. , Thompson A. , Chuang W . , Lee C. , Peng C. , Shanmuganathan G. ,Thongsawat S. , T anwandee T . , Mahachai V . , Pramoolsinsap C. , Cho M. , Han K. ,Shah S. , Foster G. , Clark P . , Pulkstenis E. , Subramanian G. , Mchutchison J. Insulinresistance is independently associated with signi¦cant hepatic ¦brosis in Asianchronic hepatitis C genotype 2 or 3 patients(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=79958783189&origin=inward) Journal ofGastroenterology and Hepatology (Australia). 26:1182-1188. 2011 citedby-count:16 AOI
29. Kaewvichit S. , Yotsawimonwat S. , T aesotikul W . , Niwatananun W . , Duangrat C. ,Wongsinsup C. , Thongsawat S. , Salee P . Bioequivalence study of the two 1.5 gcefoperazone and sulbactam IM injections in Thai healthy male volunteers(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=57149105161&origin=inward) Journal of the MedicalAssociation of Thailand. 91:1760-1764. 2008 citedby-count: 1
30. Jones-Engel L. , May C. , Engel G. , Steinkraus K. , Schillaci M. , Fuentes A. , RompisA. , Chalise M. , Aggimarangsee N. , Feeroz M. , Grant R. , Allan J. , Putra A. , WandiaI. , Watanabe R. , Kuller L. , Thongsawat S. , Chaiwarith R. , Kyes R. , Linial M. Diversecontexts of zoonotic transmission of simian foamy viruses in Asia(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=48749117459&origin=inward) Emerging InfectiousDiseases. 14:1200-1208. 2008 JIF : 5.094citedby-count: 76 AOI
31. Thongsawat S. , Maneekarn N. , Kuniholm M. , Pantip C. , Thungsuputi A. , LumlertkulD . , Bannachak D . , Nelson K. Occult hepatitis C virus infection during an outbreakin a hemodialysis unit in Thailand (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=41849139299&origin=inward) Journal of MedicalVirology . 80:808-815. 2008 JIF : 2.779citedby-count: 21 JDA
32. Nantachit N. , Thaikruea L. , Thongsawat S. , Leetrakool N. , Fongsatikul L. , SompanP . , Fong Y . , Nichols D . , Ziermann R. , Ness P . , Nelson K. Evaluation of a multiplexhuman immunode¦ciency virus-1, hepatitis C virus, and hepatitis B virus nucleicacid testing assay to detect viremic blood donors in northern Thailand(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34548757985&origin=inward) Transfusion. 47:1803-1808. 2007 JIF : 3.160citedby-count: 29 AOI JDA
33. Chitapanarux T . , Praisontarangkul O . , Thongsawat S. , Pisespongsa P . , Leerapun A.Per rectal portal scintigraphy as a useful tool for predicting esophageal varicealbleeding in cirrhotic patients (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33846988641&origin=inward) World Journal ofGastroenterology . 13:791-795. 2007 citedby-count: 4
34. Lai C. , Gane E. , Liaw Y . , Hsu C. , Thongsawat S. , Wang Y . , Chen Y . , Heathcote E. ,Rasenack J. , Bzowej N. , Naoumov N. , Di Bisceglie A. , Zeuzem S. , Moon Y . ,Goodman Z. , Chao G. , Constance B. , Brown N. T elbivudine versus lamivudine inpatients with chronic hepatitis B (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=37349120537&origin=inward) New England Journalof Medicine. 357:2576-2588. 2007 JIF : 44.016citedby-count: 643 AOI
35. Jittiwutikarn J. , Thongsawat S. , Suriyanon V . , Maneekarn N. , Celentano D . , RazakM. , Srirak N. , Vongchak T . , Kawichai S. , Thomas D . , Sripaipan T . , Netski D . ,Ananthakrishnan A. , Nelson K. epatitis C infection among drug users in northernThailand (https:/ /www scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33746093355&origin=inward) American Journal ofTropical Medicine and Hygiene. 74:1111-1116. 2006 JIF : 2.013citedby-count: 33AOI JDA
36. Kuang S. , Lekawanvijit S. , Maneekarn N. , Thongsawat S. , Brodovicz K. , Nelson K. ,Groopman J. Hepatitis B 1762T/1764A mutations, hepatitis C infection, andcodon 249 p53 mutations in hepatocellular carcinomas from Thailand(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=13944251714&origin=inward) Cancer EpidemiologyBiomarkers and Prevention. 14:380-384. 2005 JIF : 4.720citedby-count: 42 AOIJDA
37. Lau G. , Piratvisuth T . , Kang X. , Marcellin P . , Thongsawat S. , Cooksley G. , Gane E. ,Fried M. , Wan C. , Seung W . , Wen Y . , Berg T . , Flisiak R. , McCloud P . , Pluck N.Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positivechronic hepatitis B (https:/ /www scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=21244447705&origin=inward) New England Journalof Medicine. 352:2682-2695. 2005 JIF : 34.833citedby-count: 1199 AOI
38. Yousukh A. , Jutavijittum P . , Pisetpongsa P . , Chitapanarux T . , Thongsawat S. , SenbaM. , T oriyama K. Clinicopathologic Study of Hepatic Penicillium marneffei inNorthern Thailand (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0742304561&origin=inward) Archives of Pathologyand Laboratory Medicine. 128:191-194. 2004 JIF : 1.410citedby-count: 22 AOIJDA
39. Netski D. , Wang X. , Mehta S. , Nelson K. , Celentano D . , Thongsawat S. , ManeekarnN. , Suriyanon V . , Jittiwutikorn J. , Thomas D . , Ticehurst J. Hepatitis C Virus (HCV)Core Antigen Assay to Detect Ongoing HCV Infection in Thai Injection Drug Users(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=11844255837&origin=inward) Journal of ClinicalMicrobiology . 42:1631-1636. 2004 JIF : 3.565citedby-count: 15 AOI JDA
40. Thaikruea L. , Thongsawat S. , Maneekarn N. , Netski D. , Thomas D . , Nelson K. Riskfactors for hepatitis C virus infection among blood donors in northern Thailand(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=4844229244&origin=inward) Transfusion. 44:1433-1440. 2004 JIF : 3.020citedby-count: 41 AOI JDA
41. Kellow J. , Lee O . , Chang F . , Thongsawat S. , Mazlam M. , Yuen H. , Gwee K. , Bak Y . ,Jones J. , Wagner A. An Asia-Paci¦c, double blind, placebo controlled, randomized study to evaluate the e¨cacy, safety , and tolerability of tegaserod in patients withirritable bowel syndrome (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0037799916&origin=inward) Gut. 52:671-676. 2003JIF : 6.170citedby-count: 206 AOI
42. Kaewvichit S. , T aesotikul W . , Duangrat C. , Thongsawat S. , Niwatananun N. ,Niwatananun K. , Wongsinsup C. Bioequivalence Studies of Itraconazole Capsules(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0346220338&origin=inward) Farmacevtski Vestnik.
54:553-554. 2003
43. Soffer E. , Thongsawat S. , Hoogwerf B. , Shah A. Effect of acute hyperglycemia onjejunal compliance and peristaltic re§ex in healthy humans(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0032949210&origin=inward) Digestive Diseases andSciences. 44:50-55. 1999 JIF : 1.875citedby-count: 7 AOI
44. Soffer E. , Thongsawat S. , Ellerbroek S. Prolonged ambulatory duodeno-jejunalmanometry in humans: Normal values and gender effect(https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0032148062&origin=inward) American Journal ofGastroenterology . 93:1318-1323. 1998 citedby-count: 35 AOI
45. Soffer E. , Thongsawat S. Small bowel manometry: Short or long recordingsessions? (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0030979618&origin=inward) Digestive Diseases andSciences. 42:873-877. 1997 citedby-count: 22 AOISoffer E. , Thongsawat S. Clinical Value of Duodenojejunal Manometry: ItsUsefulness in Diagnosis and Management of Patients with GastrointestinalSymptoms (https:/ /www .scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0029985384&origin=inward) Digestive Diseases andSciences. 41:859-863. 1996 citedby-count: 32 AOI
46. Lim HY . , Merle P . , Weiss KH. , Yau T . , Ross P . , Mazzaferro V . , Blanc JF . , Ma YT . ,Yen CJ. , Kocsis J. , Choo SP . , Sukeepaisarnjaroen W . , Gérolami R. , Dufour JF . ,Gane EJ. , Ryoo BY . , Peck-Radosavljevic M. , Dao T . , Yeo W . , Lamlertthon W . ,Thongsawat S. , Teufel M. , Roth K. , Reis D . , Childs BH. , Krissel H. , Llovet JM.Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients withRAS-Mutated Hepatocellular Carcinoma(https:/ /www ncbi.nlm.nih.gov/pubmed/29950351) Clinical cancer research : ano¨cial journal of the American Association for Cancer Research. 24:4650-4661.2018 citedby-count: 3
47. Ferrante S. , Elbasha EH. , Piratvisuth T . , T anwandee T . , Lerdlitruangsin S. ,Thongsawat S. Adding Boceprevir Yields Better Cost-Saving for Chronic HepatitisC Genotype 1 Treatment in Thailand(https:/ /www .ncbi.nlm.nih.gov/pubmed/27202496) Value in health : the journalof the International Society for Pharmacoeconomics and Outcomes Research.17:A677. 2014
48. Soffer E. , Thongsawat S. Clinical value of duodenojejunal manometry . Itsusefulness in diagnosis and management of patients with gastrointestinalsymptoms (https:/ /www ncbi.nlm.nih.gov/pubmed/8625755) Digestive diseasesand sciences. 41:859-63. 1996 citedby-count: 4Web of Science Publications (not in Scopus & Pubmed)
49. Phrueksotsai S. , Thongsawat S. , Leerapun A. , Pinyopornpanish K. , Phrueksotsai J., Phrommintikul A. , Chattipakorn N. , Buranapin S. Effect of Dapagli§ozin onHepatic Fat, Visceral Fat and Hepatic In§ammatory Markers in Non-AlcoholicFatty Liver Disease Patients with Type 2 Diabetes HEP A TOLOGY . 68:442A-443A.2018 JIF : 13.246 JDA
50. Andrieux-Meyer I. , T an SS. , Salvadori N. , Simon F . , Cressey TR. , Said HRHM. ,Hassan MRA. , Omar H. , Tee HP . , Chan WK. , Goh KL. , Omar SFS. , Kamarulzaman A., Kumar S. , Thongsawat S. , Thetket K. , Avihingsanon A. , Khemnark S. ,Thanprasertsuk S. , Piedagnel JM. , Brenner J. , Siva S. , Asimah N. , Da Silva N. ,Pecoul B. , Lallemant M. , Murad S. Safety and e¨cacy of ravidasvir plussofosbuvir 12 weeks in non-cirrhotic and 24 weeks in cirrhotic patients withhepatitis C virus genotypes 1, 2, 3 and 6: The STORM-C-1 phase II/III trialJOURNAL OF HEP A TOLOGY . 68:S123-S124. 2018 JIF : 12.486citedby-count: 1
51. T anwandee T . , Chatsiricharoenkul S. , Thongsawat S. , Sukeepaisarnjaroen W . ,T angkijvanich P . , Komolmit P . , Avihingsanon A. , Piratvisuth T . , Sunthi P . ,Mahasanprasert T . , Matkovits T . , Conover M. , Cobb J. , Canizares C. , Sullivan-Bolyai J. Pharmacokinetics, safety and antiviral activity of CMX157, a novelprodrug of tenofovir , administered as ascending multiple doses to healthyvolunteers and Hepatitis B virus-infected subjects JOURNAL OF HEP A TOLOGY .66:S24-S25. 2017 JIF : 10.590citedby-count: 2
52. T anwandee T . , Thongsawat S. , Sukeepaisarnjaroen W . , T angkijvanich P . , KomolmitP . , Avihingsanon A. , Piratvisuth T . Pharmacokinetics, Safety and Antiviral Activityof T enofovir exalidex(TXL), a Novel Prodrug of Tenofovir , Administered asAscending Multiple Doses to HBV-Infected Subjects: A 28 Day Study FinalAnalyses HEP A TOLOGY . 66:505A-505A. 2017 JIF : 11.711
53. Hezode C. , Fried MW . , Colombo M. , Bourliere M. , Spengler U. , Ben-Ari Z. , StrasserSI. , erumalswami P . , Zamor P . , Lee WM. , Satoskar R. , Koskinas I. , Foster G. ,Sherman KE. , Thongsawat S. , T anwandee T . , Morgan L. , Qiu JJ. , Hwang P . ,Robertson M. , Nguyen BY . , Barr E. , Wahl J. , Haber B. , Chase R. , T alwani R. , DiMarco V . E¨cacy and Safety of Elbasvir/Grazoprevir in Patients with ChronicHepatitis C Virus Infection and Inherited Blood Disorders: Final Data from the C-Edge Ibld Study BLOOD. 128. 2016 JIF : 10.452
54. Leerapun A. , Pinyomahakul P . , Kijdamrongthum P . , Chitapanarux T . , Thongsawat S.Low serum HBsAg level predicts HBsAg seroclearance and sustained responsein chronic hepatitis B after stopping oral NUCs HEP A TOLOGY . 64:915A-915A.2016 JIF : 11.055
55. Llovet JM. , Merle P . , Weiss KH. , Yau T . , Ross P . , Mazzaferro V . , Blanc JF . , Ma YT . ,Yen CJ. , Kocsis J. , Choo SP . , Sukeepaisarnjaroen W . , Gerolami R. , Dufour JF . ,Gane EJ. , Ryoo BY . , Peck-Radosavljevic M. , Dao T . , Yeo W . , Lamlertthon W . ,Thongsawat S. , Teufel M. , Krissel H. , Lim HY . Phase II Studies with Refametinib orRefametinib Plus Sorafenib in Patients with Mutant RAS HepatocellularCarcinoma (HCC) HEP A TOLOGY . 64:621A-621A. 2016 JIF : 11.055citedby-count:1
56. Thanapirom K. , Suksawatamnuay S. , Sukeepaisarnjaroen W . , T anwandee T . ,Charatcharoenwitthaya P . , Thongsawat S. , Leerapun A. , Piratvisuth T . , BoonsirichanR. , Bunchorntavakul C. , Pattanasirigool C. , Pornthisarn B. , T antipanichtheerakul S. ,Sripariwuth E. , Jeamsripong W . , Sanpajit T . , Poovorawan Y . , Komolmit P . Theassociation of S267F variant on NTCP (SLC10A1), a hepatitis B viral surfacereceptor , and treatment response with pegylated interferon in chronic hepatitis Bpatients: a multicenter study HEP A TOLOGY . 64:291A-291A. 2016 JIF : 11.055
57. Pinyopornpanish K. , Kijdamrongtham P . , Soontornpun A. , Teeyasoontranon W . ,Angkurawaranon C. , Thongsawat S. The effect of prucalopride on gastricemptying in Parkinson ‘ s disease patients, a pilot randomized, open-label studyJOURNAL OF GASTROENTEROLOGY AND HEP A TOLOGY . 31:113-113. 2016 JIF :3.504 JDA
58. Pisespongsa P . , Thinrungroj N. , Kijdamrongthum P . , Leerapun A. , Chitapanarux T . ,Thongsawat S. , Praisontharangkul OA. Endoscopic Variceal Ligation (EVL) is Safein Cirrhotic Patients with Severe Thrombocytopenia DIGESTION. 91:97-97. 2015
59. Thanapirom K. , Suksawatamnuay S. , Poovorawan K. , Sukeepaisarnjaroen W . ,T anwandee T . , Thongsawat S. , Piratvisuth T . , Boonsirichan R. , Bunchorntavakul C. ,Pattanasirigool C. , Pornthisarn B. , T antipanichtheerakul S. , Sripariwuth E. ,Jeamsripong W . , Sanpajit T . , Komolmit P . Genetic Variation in Vitamin D PathwayCYP2R1 gene predict sustained HBeAg seroconversion across chronic hepatitisB patients treated with peginterferon: Multicenter study HEP A TOLOGY . 62:1004A-1004A. 2015 JIF : 11.190
60. Thanapirom K. , Suksawatamnuay S. , Sukeepaisarnjareon W . , T anwandee T . ,Thongsawat S. , Leerapun A. , Piratvisuth T . , Boonsirichan R. , Bunchorntavakul C. ,Pattanasirigool C. , Pornthisarn B. , T antipanichtheerakul S. , Sripariwuth E. ,Jeamsripong W . , Sanpajit T . , Poovorawan Y . , Komolmit P . INTERFERON-GAMMA-INDUCIBLE PROTEIN 10 PROMOTER POL YMORPHISM RELA TED WITH END-OF-TREA TMENT HBsAg LEVELS AND HAD COMPLEMENTARY ROLE IN PREDICTIONOF SUSTAINED VIROLOGIC RESPONSE TO PEGINTERFERON IN HBeAg-NEGA TIVE CHRONIC HEP A TITIS B: MUL TICENTER STUDY JOURNAL OFHEP A TOLOGY . 62:S546-S547. 2015 JIF : 10.401
61. Pisespongsa P . , Bhatia P . , Thongsawat S. , Leerapun A. , Kitdumrongthum P . LowVolume Polyethylene Glycol-Electrolyte Lavage Solution Plus Simple Adjuvant Isas Effective as Sodium Phosphate Solution in the Preparation of Patients forColonoscopy DIGESTION. 91:89-89. 2015 JIF : 2.032
62. Padunwanitchkul P . , Pisespongsa P . , Praisontarangkul O . , Thongsawat S. ,Chitapanarux T . , Leerapun A. , Kitdumrongthum P . Natural History and PrognosticFactors of Acute Complicated Diverticular Diseases in Thailand DIGESTION.91:88-89. 2015 JIF : 2.032
63. Thanapirom K. , Suksawatamnuay S. , Sukeepaisarnjaroen W . , T anwandee T . ,Thongsawat S. , Piratvisuth T . , Boonsirichan R. , Bunchorntavakul C. , PattanasirigoolC. , Pornthisarn B. , T antipanichtheerakul S. , Sripariwuth E. , Jeamsripong W . ,Sanpajit T . , Komolmit P . The Association of vitamin D metabolic pathway relatedgenes polymorphisms with virologic response in HBeAg-negative patientstreated with pegylated interferon: Multicenter study HEP A TOLOGY . 62:1019A-1019A. 2015 JIF : 11.190
64. Thanapirom K. , Suksawatamnuay S. , Poovorawan K. , Sukeepaisarnjaroen W . ,T anwandee T . , Thongsawat S. , Leerapun A. , Piratvisuth T . , Boonsirichan R. ,Bunchorntavakul C. , Pattanasirigool C. , Pornthisarn B. , T antipanichtheerakul S. ,Sripariwuth E. , Jeamsripong W . , Sanpajit T . , Komolmit P . The Single NucleotidePolymorphism in the Vitamin D Pathway DHCR7 Gene and Pre-Treatment HBV-DNA Strongly Predict HBeAg Loss in HBeAg-Positive Chronic Hepatitis B PatientsTreated With Pegylated Interferon: Multicenter Study GASTROENTEROLOGY .148:S1066-S1066. 2015 JIF : 13.926
65. Chitapanarux T . , Thongsawat S. , Pisespongsa P . , Leerapun A. , Kijdamrongthum P .Effect of bi¦dobacterium longum on PPI-based triple therapy for eradication ofHelicobacter pylori: a prospective, randomized study JOURNAL OFGASTROENTEROLOGY AND HEP A TOLOGY . 29:23-23. 2014 JIF : 3.325citedby-count: 1Gane EJ. , Lai CL. , Xie Q. , Liaw YF . , Thongsawat S. , Chan HL Y . , Wang Y . , Hwang SG., Safadi R. , Jung M. , Uddin A. , Janssens N. , Trylesinski A. EVALUA TION OFESTIMA TED GLOMERULAR FIL TRA TION RA TE DURING CONTINUOUS 4-YEARTREA TMENT WITH TELBIVUDINE IN P A TIENTS WITH BRIDGINGFIBROSIS/CIRRHOSIS JOURNAL OF HEP A TOLOGY . 60:S426-S426. 2014 JIF :9.858
66. Thinrungroj N. , Pisespongsa P . , Kijdamrongthum P . , Leerapun A. , Chitapanarux T . ,Thongsawat S. , Praisontarangkul OA. Alginate Accelerates Healing of Post-Endoscopic Variceal Ligation Ulcers: a Randomized-Controlled TrialGASTROINTESTINAL ENDOSCOPY . 75:457-458. 2012 JIF : 5.647citedby-count: 1Moreno C. , Berg T . , T anwandee T . , Thongsawat S. , Van Vlierberghe H. , Zeuzem S. ,Lenz O . , Peeters M. , Sekar V . , De Smedt G. Antiviral activity of TMC435monotherapy in patients infected with HCV genotypes 2-6: TMC435-C202, aphase ha, open-label study JOURNAL OF HEP A TOLOGY . 56:1247-1253. 2012 JIF: 9.334citedby-count: 77
67. Pisespongsa P . , Thepsen K. , Kijdamrongdham P . , Leerapun A. , Chitapanarux T . ,Thongsawat S. , Praisontarangkul OA. Causes of mortality in thai patients withacute upper gastrointestinal bleeding (AUGIB) and novel clinical score forpredicting mortality JOURNAL OF GASTROENTEROLOGY AND HEP A TOLOGY .27:433-433. 2012 JIF : 2.410
68. Leerapun A. , Thaikrua L. , Pisespongsa P . , Chitapanarux T . , Praisontarangkul OA. ,Thongsawat S. Clinical feature and prognostic factors for liver cancer amongThailand Referral Center JOURNAL OF GASTROENTEROLOGY ANDHEP A TOLOGY . 27:267-268. 2012 JIF : 2.410Disease burden and risk of HCC of Hepatitis B in the Asia-Paci¦c JOURNAL OFGASTROENTEROLOGY AND HEP A TOLOGY . 27:6-7. 2012 JIF : 2.410
69. Leelakusolvong S. , Charatcharoenwitthaya P . , Maneerattanaporn M. , Piyanirun W . ,Chakkhapak S. , Kositchaiwat C. , Ovartlarnporn B. , Chunler trith K. , Surangsrirat S. ,Gonlachavit S. , Mahachai V . , Thongsawat S. , Kachintorn U. , Anuras S. Prevalenceof lower functional gastrointestinal disorders and the associated factors amongThai healthy subjects JOURNAL OF GASTROENTEROLOGY AND HEP A TOLOGY .27:149-149. 2012 JIF : 2.410
70. Leelakusolvong S. , Charatcharoenwitthaya P . , Maneerattanaporn M. , Piyanirun W . ,Chakkhapak S. , Kositchaiwat C. , Ovartlarnporn B. , Chunler trith K. , Surangsrirat S. ,Gonlachavit S. , Mahachai V . , Thongsawat S. , Kachintorn U. , Anuras S. Prevalenceof upper functional gastrointestinal disorders and the associated factors amongThai healthy subjects JOURNAL OF GASTROENTEROLOGY AND HEP A TOLOGY .27:149-150. 2012 JIF : 2.410
71. Pisespongsa P . , Intasri W . , Kijdamrongdham P . , Leerapun A. , Chitapanarux T . ,Thongsawat S. , Praisontarangkul OA. Recent increase of antibiotic-resistantpathogens in Spontaneous Bacterial Peritonitis (SBP) in Northern ThailandJOURNAL OF GASTROENTEROLOGY AND HEP A TOLOGY . 27:265-266. 2012 JIF :2.410
72. Leerapun A. , Soontornpun A. , Pisespongsa P . , Chitapanarux T . , Kijdamrongthum P . ,Thongsawat S. Ribavirin-induced anemia: Incidence and impact to treatmentresponse of chronic hepatitis C JOURNAL OF GASTROENTEROLOGY ANDHEP A TOLOGY . 27:267-267. 2012 JIF : 2.410
73. Chaiwatanarat T . , Vasavid P . , Pusuwan P . , Sritara C. , Roysri K. , Namwongprom S. ,Kuanrakcharoen P . , Premprabha T . , Chunler trith K. , Thongsawat S. , SirinthompunyaS. , Ovartlarnporn B. , Kachintorn U. , Leelakusolvong S. , Chakkaphak S. ,Gonlachanvit S. Normal Solid Gastric Emptying (GE) Measured by Scintigraphy inThai Healthy Volunteers: Preliminary Results of a Multicenter StudyGASTROENTEROLOGY . 140:S758-S758. 2011 JIF : 12.899 JDA
74. Foster G. , Flisiak R. , Chuang WL. , George J. , Rasenack J. , Sood A. , Komolmit P . ,Thongsawat S. , T anwandee T . , Sola R. , Sukeepaisarnjaroen W . , Weltman M. , Yin Y . ,Feutren G. , Brown K. RESPIRA TORY AL TERA TIONS IN GENOTYPE 2/3 CHRONICHEP A TITIS C P A TIENTS TREA TED WITH PEGYLA TED INTERFERON ORALBINTERFERON-ALF A-2B PLUS RIBAVIRIN IN A RANDOMIZED STUDY JOURNAL
OF HEP A TOLOGY . 54:S171-S172. 2011 JIF : 7.818
75. Moreno C. , Berg T . , T anwandee T . , Thongsawat S. , Van Vlierberghe H. , Zeuzem S. ,Lenz O . , Peeters M. , Sekar VJ. , De Smedt G. A PHASE IIA, OPEN-LABEL STUDY TOASSESS THE ANTIVIRAL ACTIVITY OF TMC435 MONOTHERAPY IN P A TIENTSINFECTED WITH HCV GENOTYPES 2-6 HEP A TOLOGY . 52:749A-750A. 2010 JIF :11.355citedby-count: 5
76. Pisespongsa P . , Praisontarangkul OA. , Hongsongkiat S. , Thongsawat S. , LeerapunA. , Chitapanarux T . Changing in epidemiology of peptic ulcer disease (PUD) andHelicobacter pylori infection in Thailand JOURNAL OF GASTROENTEROLOGYAND HEP A TOLOGY . 25:A72-A72. 2010 JIF : 2.275Xie Q. , Shi GF . , Thongsawat S. , Liaw YF . , Chan HL Y . , Safadi R. , Wan M. , Hwang SG., Wei L. , Ren H. , T anwandee T . , Bao WB. , T rylesinski A. TELBIVUDINE SWITCH INLAMIVUDINE PRETREA TED CHRONIC HEP A TITIS B P A TIENTS PROVIDESSUSTAINED VIRAL SUPPRESSION FOR 2 YEARS HEP A TOLOGY . 52:564A-565A.2010 JIF : 11.355
77. Liaw YF . , Wursthorn K. , Thongsawat S. , Zhou XQ. , Hwang SG. , Chutaputti A. , TeoEK. , Gane EJ. , Jung M. , Wedemeyer H. , Avila C. TELBIVUDINE-INDUCED HBEAGSEROCONVERSION IN CHRONIC HEP A TITIS B (CHB) IS DURABLE DURING 2YEARS OFF-TREA TMENT FOLLOW-UP JOURNAL OF HEP A OLOGY . 52:S391-S391. 2010 JIF : 7.056citedby-count: 5
78. Gane EJ. , Chan HL. , Choudhuri G. , Suh DJ. , Chutaputti A. , Safadi R. , T anwandee T ., Thongsawat S. , Assy N. , Sarin SK. , Bao W . , T rylesinski A. , Avila C. TREA TMENTOF DECOMPESA TED HBV-CIRRHOSIS: RESUL TS FROM 2-YEARS RANDOMIZEDTRIAL WITH TELBIVUDINE OR LAMIVUDINE JOURNAL OF HEP A TOLOGY . 52:S4-S4. 2010 JIF : 7.056citedby-count: 13
79. Piratvisuth T . , Pramoolsinsap C. , Chutaputti A. , T anwandee T . , Thongsawat S. ,Sukarom I. , Tinmanee S. , Berger W . COST -EFFECTIVENESS ANAL YSIS OFPEGINTERFERON ALF A-2A (40 KD) PLUS RIBAVIRIN VERSUS NO TREA TMENT INP A TIENTS WITH CHRONIC HEP A TITIS C (CHC), GENOTYPE 1 FROM A P AYERPERSPECTIVE IN THAILAND HEP A TOLOGY . 50:714A-715A. 2009 JIF : 10.734
80. Wang YM. , Thongsawat S. , Gane EJ. , Liaw YF . , Jia JD . , Manns MP . , Hou JL. , ChanHL Y . , Papatheodoridis GV . , Wan MB. , Niu JQ. , Bao WB. , Lopez PM. , Naoumov NV .EFFICACY AND SAFETY OUTCOMES AFTER 4 YEARS OF TELBIVUDINETREA TMENT IN P A TIENTS WITH CHRONIC HEP A TITIS B (CHB) HEP A TOLOGY .50:533A-533A. 2009 JIF : 10.734citedby-count: 6
81. Thongsawat S. , Piratvisuth T . , Pramoolsin-Sap C. , Chutaputti A. , T anwandee T . ,Berger W . , Sukarom I. , Tinmanee S. PEGINTERFERON ALF A-2A (40KD) PLUSRIBAVIRIN IS DOMINANT WITH LARGE COST -SA VINGS VERSUS NO TREA TMENTIN P A TIENTS WITH CHRONIC HEP A TITIS C (CHC), GENOTYPE 2/3: A COST -EFFECTIVENESS ANAL YSIS FROM THE THAI P AYER PERSPECTIVEHEP A TOLOGY . 50:704A-705A. 2009 JIF : 10.734
82. Thongsawat S. , Piratvisuth T . , Pramoolsinsap C. , Chutaputti A. , T anwandee T . ,Sukarom I. , Tinmanee S. RESOURCE UTILIZA TION AND DIRECT MEDICAL COSTOF CHRONIC HEP A TITIS C (CHC) IN THAILAND: A HEAVY BUT MANAGEABLEECONOMIC BURDEN VALUE IN HEAL TH. 12:A348-A348. 2009 JIF : 3.387
83. Chitapanarux T . , Praisontarangkul OA. , Thongsawat S. , Pisespongsa R. , LeerapunA. Rebamipide treatment for chronic gastritis with long-term NSAID useDIGESTION. 77:66-66. 2008 JIF : 1.826
84. Pisespongsa P . , Sripotong S. , Chitapanarux T . , Leerapun A. , Thongsawat S. ,Praisontarangkul OA. Serum-ascites albumin concentration gradient (SAAG) morethan 1.5 g/dl predicts esophageal variceal hemorrhage HEP A TOLOGY . 46:602A-602A. 2007 JIF : 9.792
85. Lai CL. , Chang TT . , Chao YC. , T anwandee T . , Thongsawat S. , Lee SD . , Angus P . ,Zink R. , Zhu J. , Brett-Smith H. , Neo BL. Continued virologic and biochemicalimprovement through 96 weeks of entecavir treatment in HBeAg(-) chronichepatitis B patients (Study ETV-027) JOURNAL OF GASTROENTEROLOGY ANDHEP A TOLOGY . 21:A128-A128. 2006 JIF : 1.796
86. Lai CL. , Chang TT . , Chao YC. , T anwandee T . , Thongsawat S. , Lee SD . , Angus P . ,Zink R. , Zhu J. , Brett-Smith H. , Neo BL. Continued virologic and biochemicalimprovement through 96 weeks of entecavir treatment in HBeAg(-) chronichepatitis B patients (study ETV-027) JOURNAL OF GASTROENTEROLOGY ANDHEP A TOLOGY . 21:A31-A31. 2006 JIF : 1.796
87. Lau GKK. , Piratvisuth T . , Luo KX. , Marcellin P . , Thongsawat S. , Cooksley G. , GaneE. , Fried MW . , Popescu M. , Wu J. Durability of response and occurrence of lateresponse to peginterferon alpha-2a (40KD) [PEGASYS] one year post-treatment inpatients with HBeAg-positive chronic hepatitis B JOURNAL OF HEP A TOLOGY .44:S23-S24. 2006 JIF : 4.816citedby-count: 18
88. Lau GKK. , Piratvisuth T . , Thongsawat S. , Paik SW . , Fried MW . , Luo KX. , Gane E. ,Marcellin P . , Popescu M. , Wu J. Durability of response to peginterferon alfa-2a (40KD) (PEGASYS (R)) in Asian patients with HBeAg-positive chronic hepatitis B: 12month follow-up data from a large, randomized study JOURNAL OFGASTROENTEROLOGY AND HEP A TOLOGY . 21:A88-A88. 2006 JIF : 1.796
89. Lim SG. , Lai CL. , Gane E. , Liaw YF . , Thongsawat S. , Wang YM. , Chen YG. ,Heathcote EJ. , Rasenack J. , Naoumov N. , Chao G. , Fielman B. , Brown NA. E¨cacy ,safety , and predictors of response at 1 year from a phase III comparison oftelbivudine versus lamivudine in patients with chronic hepatitis B JOURNAL OFGASTROENTEROLOGY AND HEP A TOLOGY . 21:A458-A459. 2006 JIF : 1.796
90. Thaikruea L T . , Niwes NN. , Thongsawat ST . , Litrakoon LN. , Fonksatidki LF . , SompanPS. , Heaton AH. , Nichols DN. , Nelson KN. Evaluation of accepted blood donorswith a multiplex nucleic acid test (NA T)at Chiang Mai university hospital,Thailand VOX SANGUINIS. 91:88-89. 2006 JIF : 1.762 JDA
91. Naoumov N. , Lai CL. , Gane E. , Liaw YF . , Thongsawat S. , Wang Y . , Heathcote EJ. ,Rasenack J. , Bzowej N. , Chaolo G. , Brown N. Evidence of central circadiandisruption in patients with cirrhosis JOURNAL OF HEP A TOLOGY . 44:S276-S277.2006 JIF : 4.816citedby-count: 1
92. Brodovicz K. , Kuang SY . , Thetket S. , Thongsawat S. , Maneekarn N. , Groopman JD . ,Nelson KE. Hepatocellular carcinoma in Thailand: Role of hepatitis B and Cinfections, a§atoxin-speci¦c p53 and hepatitis B A1762T/G1764A doublemutations, and betel nut use HEP A TOLOGY . 44:509A-510A. 2006 JIF : 10.416JDA
93. Lim SG. , Lai CL. , Thongsawat S. , Wang Y . , Chen Y . , Rasenack J. , Naoumov N. ,Chao G. , Brown N. Maximal early HBV suppression in nucleoside-treated hepatitisB patients is associated with optimal virologic and clinical e¨cacy at one yearJOURNAL OF CLINICAL VIROLOGY . 36:S245-S245. 2006 JIF : 2.447
94. Gane E. , Lai CL. , Hsu CW . , Thongsawat S. , Wang YM. , Chen Y . , Leung N. , Zhou XQ., Moon YM. , Chao YC. , Zeuzem S. , Chutaputti A. , Kim DJ. , Chao G. , Brown N.Maximal early HBV suppression in telbivudine-treated hepatitis B patients isassociated with optimal virologic and clinical e¨cacy at one year JOURNAL OFGASTROENTEROLOGY AND HEP A TOLOGY . 21:A89-A89. 2006 JIF : 1.796citedby-count: 1
95. Moon YM. , Lai CL. , Gane E. , Thongsawat S. , Wang YM. Optimal virologic andclinical e¨cacy at one year is associated with maximal early HBV suppression innucleoside-treated hepatitis B patients JOURNAL OF GASTROENTEROLOGY ANDHEP A TOLOGY . 21:A24-A24. 2006 JIF : 1.796
96. Zeuzem S. , Lai CL. , Gane E. , Liaw YF . , Thongsawat S. , Wang Y . , Chen Y . ,Heathcote J. , Rasenack J. , Bzowej N. , Naoumov N. , Chao G. , Fielman B. , Brown N.Optimal virologic and clinical e¨cacy at one year is associated with maximalearly HBV suppression in nucleoside-treated hepatitis B patients JOURNAL OFHEP A TOLOGY . 44:S24-S24. 2006 JIF : 4.816citedby-count: 3
97. Gane E. , Lai CL. , Liaw YF . , Thongsawat S. , Wang Y . , Chen Y . , Heathcote J. ,Rasenack J. , Bzowej N. , Naoumov N. , Chao G. , Fielman B. , Brown N. Phase IIIcomparison of telbivudine vs lamivudine in HBeAg-positive patients with chronichepatitis B: E¨cacy, safety , and predictors of response at 1 year JOURNAL OFHEP A TOLOGY . 44:S183-S184. 2006 JIF : 4.816citedby-count: 7
98. Bzowej N. , Lai C. , Gane E. , Liaw Y . , Thongsawat S. , Wang Y . , Chen Y . , Heathcote J., Rasenack J. , Naoumov N. , Chao G. , Fielman B. , Brown N. Phase III comparisonof telbivudine vs lamivudine in patients with chronic hepatitis B: E¨cacy, safety ,and predictors of response at 1 year GASTROENTEROLOGY . 130:A765-A766.2006 JIF : 13.092citedby-count: 5
99. Marcellin P . , Lau GKK. , Piratvisuth T . , Jin R. , Lu ZM. , Lai MY . , Thongsawat S. ,Ramakrishnan B. , Popescu M. Responses to peginterferon alfa-2a (40 KD)(PEGASYS) treatment are durable in Asian patients with HBeAg-negative CHB: 12month follow-up data from a large randomised study JOURNAL OFGASTROENTEROLOGY AND HEP A TOLOGY . 21:A140-A141. 2006 JIF : 1.796
100. Fried MW . , Lau GKK. , Liaw YF . , Luo KX. , Piratvisuth T . , Cooksley G. , Marcellin P . ,Thongsawat S. , Button P . Role of baseline and on-treatment quantitative HBeAg inpredicting response to peginterferon alfa-2a (40KD) (PEGASYS (R)) monotherapyin chronic hepatitis B JOURNAL OF GASTROENTEROLOGY AND HEP A TOLOGY .21:A72-A72. 2006 JIF : 1.796
101. Lai CL. , Gane E. , Thongsawat S. , Wang YM. , Heathcote J. , Moon YM. , Chen Y . , LuWL. , Niu J. , Lim SG. , Hou JL. , Yin YK. , Naoumov N. , Bzowej N. , Chao G. , FielmanB. , Brown N. T elbivudine (LdT) compared to lamivudine for treatment of chronichepatitis B: results from GLOBE, an international phase III trial JOURNAL OFGASTROENTEROLOGY AND HEP A TOLOGY . 21:A129-A130. 2006 JIF : 1.796
102. Lai CL. , Gane E. , Liaw YF . , Thongsawat S. , Chen YG. , Lu WL. T elbivudine displaysconsistent antiviral e¨cacy across patient subgroups for the treatment ofchronic hepatitis B: results from the globe study JOURNAL OFGASTROENTEROLOGY AND HEP A TOLOGY . 21:A28-A29. 2006 JIF : 1.796
103. Thongsawat S. , Lai CL. , Gane E. , Chao G. , Fielman B. , Brown N. T elbivudinedisplays consistent antiviral e¨cacy across patient subgroups for the treatmentof chronic hepatitis B: Results from the GLOBE study JOURNAL OFHEP A TOLOGY . 44:S49-S49. 2006 JIF : 4.816citedby-count: 4
104. DiBisceglie A. , Lai CL. , Gane E. , Chen YC. , Thongsawat S. , Wang YM. , Chen YG. ,Heathcote EJ. , Zeuzem S. , Rasenack J. , Bzowej N. , Han SH. , Naoumov N. , HwangSG. , Lim SG. , Chao GC. , Fielman BA. , Brown NA. T elbivudine globe trial: Maximalearly HBV suppression is predictive of optimal two-year e¨cacy in nucleoside-treated hepatitis B patients HEP A TOLOGY . 44:230A-231A. 2006 JIF : 10.416citedby-count: 52
105. Lai CL. , Gane E. , Hsu CW . , Thongsawat S. , Wang YM. , Chen YG. , Heathcote EJ. ,Rasenack J. , Bzowej N. , Naoumov N. , Zeuzem S. , Di Bisceglie A. , Chao GC. ,Constance BAF . , Brown NA. Two-year results from the globe trial in patients withhepatitis B: Greater clinical and antiviral e¨cacy for telbivudine (LDT) vs.lamivudine HEP A TOLOGY . 44:222A-222A. 2006 JIF : 10.416citedby-count: 83
106. Nelson KE. , Nantachit N. , Thaikrurea L. , Thongsawat S. , Litrakoon N. , FonksatidkilL. , Sompan P . , Nichols D . , Heaton A. Utility of multiplex nucleic acid test (NA T)screening of accepted blood donors in Nor thern Thailand TRANSFUSION.46:102A-102A. 2006 JIF : 3.708 JDA
107. Piratvisuth T . , Lu KX. , Marcellin P . , Chang WY . , Berg T . , Flisiak R. , Chao YC. , PaikSW . , Thongsawat S. , McCloud P . Effect of AL T §ares on e¨cacy and safety ofpeginterferon alpha-2a (40kDa) (Pegasys (R)), peginterferon alpha-2a pluslamivudine and lamivudine in HBeAg-positive chronic hepatitis B (CHB)JOURNAL OF HEP A TOLOGY . 42:189-190. 2005 JIF : 5.283citedby-count: 4
108. Cooksley G. , Manns M. , Lau GKK. , Liaw YF . , Marcellin P . , Chow WC. , ThongsawatS. , Gane E. , Fried MW . , Zahm F . Effect of genotype and other baseline factors onresponse to peginterferon alpha-2a (40 kDa) (PEGASYS (R)) in HBeAg-POSITIVEchronic hepatitis B: Results from a large, randomised study JOURNAL OFHEP A TOLOGY . 42:30-31. 2005 JIF : 5.283citedby-count: 23
109. Kuang SY . , Lekawanvijit S. , Maneekarn N. , Thongsawat S. , Brodovicz K. , Nelson K., Groopman JD . Hepatitis B 1762(T)/1764(A) mutations, hepatitis C infection, andcodon 249 p53 mutations in hepatocellular carcinomas from Thailand CANCEREPIDEMIOLOGY BIOMARKERS & PREVENTION. 14:380-384. 2005 citedby-count:37 JDA
110. Lumlertgul D . , Thungsuputi A. , Thongsawat S. , Maneekarn N. , Bunnachak D . ,Pantip C. , Kuniholm M. , Nelson K. HEP A TITIS C AMONG HEMODIAL YSISPATIENTS IN NORTHERN THAILAND: PREVALENCE, RISK F ACTORS ANDGENOTYPE DISTRIBUTION NEPHROLOGY . 10:A186-A186. 2005 JIF : 0.229 JDA
111. Lai CL. , Gane E. , Liaw YF . , Thongsawat S. , Wang YM. , Chen YG. , Heathcote EJ. ,Rasenack J. , Bzowej N. , Naoumov N. , Chao G. , Constance BF . , Brown NA. Maximalearly HBV suppression is predictive of optimal virologic and clinical e¨cacy innucleoside-treated hepatitis B patients: Scienti¦c observations from a largemultinational trial (the GLOBE study) HEP A TOLOGY . 42:232A-233A. 2005 JIF :9.503citedby-count: 9
112. Lau GKK. , Piratvisuth T . , Luo KX. , Marcellin P . , Thongsawat S. , Gane E. , Fried MW . ,Cooksley G. , Button P . , Liaw YF . Peginterferon alpha-2a (40 kDa) (PEGASYS (R))versus peginterferon lpha-2a plus lamivudine versus lamivudine in HBeAg-POSITIVE chronic HBV: Effect of previous treatment and drug exposure onsustained response JOURNAL OF HEP A TOLOGY . 42:15-15. 2005 JIF : 5.283citedby-count: 6
113. Fried MW . , Liaw YF . , Luo KX. , Lau GK. , Piratvisuth T . , Cooksley G. , Marcellin P . ,Thongsawat S. , Mai C. , Flisiak R. , McCloud P . , Why D . , Pluck N. Role of baselineand on-treatment quantitative HBeAg in predicting response to peginterferonalfa-2a (40KD) (PEGASYS (R)) monotherapy in a large, multinational trial ofpatients with chronic hepatitis B HEP A TOLOGY . 42:268A-268A. 2005 JIF : 9.503citedby-count: 4
114. Lai CL. , Gane E. , Liaw YF . , Thongsawat S. , Wang YM. , Chen YG. , Heathcote EJ. ,Rasenack J. , Bzowej N. , Naoumov N. , Chao G. , Constance BF . , Brown NA.T elbivudine (LdT) vs. lamivudine for chronic hepatitis B: First-year results fromthe international phase III globe trial HEP A TOLOGY . 42:748A-748A. 2005 JIF :9.503citedby-count: 42
115. Chitapanarux T . , Sudjaritruk S. , Thongsawat S. , Pisespongsa P . , PraisontarangkulO . Three-day versus ¦ve-day treatment with somatostatin or its derivative toprevent early variceal rebleeding in cirrhosis. GASTROENTEROLOGY . 128:A733-A733. 2005 JIF : 12.718citedby-count: 1
116. Nelson K. , Maneevkarn N. , Thongsawat S. , Pantip C. , Kawichai S. , Thomas DL. Therole of HIV infection in the heterosexual transmission of hepatitis C virus (HCV)in Thailand CLINICAL INFECTIOUS DISEASES. 33:1248-1248. 2001 JIF : 3.199